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ABSTRACT 
A multitude of biological processes involve membranes and their associated membrane 
proteins. The interactions of these biological molecules lead to perturbations in their structure 
and dynamics. Understanding the variations in the constitution of these molecules as the result of 
functional interactions will provide insights into various biological processes. In this work, we 
employ solution and solid-state NMR to observe changes in dynamics and conformation of both 
membranes and membrane associated proteins upon interaction with other biological molecules. 
Initial studies focus on the interaction of neurological proteins alpha-synuclein and endosulfine-
alpha. Using chemical shift perturbation mapping we detail interactions of membrane bound 
alpha-synuclein with cAMP-regulated phosphoproteins, ARPP-19 and endosulfine-alpha. 
Additionally, we report that endosulfine-alpha is an intrinsically unstructured protein that 
undergoes a conformational change upon binding to membranes and detail the effects of 
phosphorylation on these structures. Furthermore, using a combination of solution and solid-state 
NMR, we investigate important interactions involved in blood coagulation. Structural and 
dynamics data of Ca2+-induced clusters of phosphatidylserine in membranes, important in blood 
clotting, is investigated using isotopically 13C, 15N-labeled phosphatidylserine in lipid bilayers. 
Finally, backbone resonances of the soluble, extracellular domain of tissue factor (absent the 
membrane binding transmembrane helix) are assigned in solution and nanocrystalline samples by 
solution and solid-state NMR respectively. The chemical shifts are then used to investigate 
changes in the extracellular domain of tissue factor when bound to the membrane by its native 
transmembrane helix.  
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CHAPTER 1 
Introduction 
1.1 Preface 
Membranes and their associated proteins frequently function in an interdependent manor 
where conformational changes in proteins and/or the membrane bilayer instigate critical 
biological processes (1). Studies of these conformational changes are crucial for elucidating the 
underlying physical bases behind these important biological processes. Nuclear magnetic 
resonance spectroscopy (NMR) is a powerful tool used in the investigation of both chemical 
structures and dynamic chemical interactions, the essential components of biological systems and 
processes. Furthermore, NMR is uniquely suited to interrogate molecular systems in either 
membranous (solid-state NMR) or aqueous (solution NMR) environments, and to track protein 
conformational changes induced by its environment or cofactors without solving additional 
structures.  This gives NMR a distinct advantage over X-ray crystallography, which requires 
single crystals for each protein conformation; the difficulties of crystallizing membrane proteins 
have been reviewed extensively due to the importance of numerous membrane proteins as drug 
targets (2).  
This dissertation focuses on the application of NMR spectroscopy to discern the 
conformations of membranes and associated proteins in several systems. In chapters 3, 4 and 5, 
two peripheral membrane proteins involved in neurobiological processes, alpha-synuclein and 
endosulfine-alpha, are investigated. Chapters 6 through 8 focus on membrane-protein 
interactions involved in blood coagulation with emphasis on the protein-membrane interactions 
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of tissue factor (TF) and the structure and dynamics of Ca2+-induced phosphatidylserine clusters 
in membranes. 
1.2 Conformational Changes of Membranes-Protein Interactions 
Eukaryotic cells separate the interior aqueous cytosol from the external environment by a 
thin double layer of lipids embedded with proteins called the plasma membrane (1).  Inside the 
cell membranes segregate various organelles from the cytosol. Though, there are differences in 
the content and specific function of each membrane, they share many common characteristics 
(1). Each membrane is a bilayer of lipids held together by noncovalent interactions where the 
polar headgroup of the lipid interact with the aqueous environment while the hydrophobic tails of 
the lipids interact with each other forming the hydrophobic interior of the bilayer. The membrane 
bilayer is fluid and dynamic, yet it maintains a barrier to the passage of most water-soluble 
molecules. Associated with the membrane are proteins that serve various biological functions, 
from cell signaling to transport/channeling of ions, proteins and other small molecules across the 
membrane. Though membranes have been classically thought of as a chemically inert 
hydrophobic barrier and a platform for protein-protein interactions (3); a more modern 
understanding has evolved: membranes and proteins work concertedly to carry out biological 
processes (1, 4). 
Two main classes of proteins are associated with membranes, integral membrane proteins 
and peripheral membrane proteins. Integral membrane proteins have a section of the protein 
inserted into the interior hydrophobic region of the lipid bilayer. Peripheral membrane proteins 
are associated with the surface of the membrane through noncovalent interactions or, in other 
cases, tethered to hydrophobic molecules that insert into the bilayer, anchoring the protein to the 
surface of the membrane. Interactions of these proteins with substrates, cofactors and the 
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membrane bilayer often cause slight changes in the protein structure that are essential for 
function (1). Understanding these conformational changes will be paramount to understanding 
the function of these proteins (1). 
The membrane also plays a critical role in the biological function of the cell (1, 4), and; like 
proteins, the membrane function is dependent on the composition, dynamics and structure (1, 4). 
Cells maintain tight control on the amount and type of lipids present in the bilayer (5, 6). More 
specifically, scramblases and flipases, membrane proteins that facilitate lipid transport between 
bilayer leaflets, segregate certain lipid types to either the inner or outer leaflet (5, 6). This allows 
for temporal and spatial control over specific biological processes. For instance, many signaling 
mechanisms are triggered upon the appearance of phosphatidylserine on the external leaflet of 
the plasma membrane, a signal of cell injury that prompts apoptosis (6).  
Membrane dynamics are often best understood as the phase behavior of the lamellar lipid 
bilayer, though, non-bilayer lipid phases certainly are important for various biological functions 
including, fusion, fission and pore formation (7). Lipid phases may be defined by the order 
parameter and lipid diffusion. The order parameter (S) describes the average orientation of the 
lipids in the bilayer as compared to a perpendicular line to the membrane surface. The parameter 
S can have values from 0 (no order) to 1 (rigid order). Lipid diffusion refers to the propensity of 
lipids to disperse laterally along the bilayer. The two parameters are not completely independent 
of one another. Molecules in a highly ordered state are most likely restricted in their motion and 
conversely molecules with rapid diffusion are anticipated to have little order, though both 
parameters are needed for a complete explanation of the system.  
Lipid phases depend on several factors, including, temperature, lipid composition and protein 
interactions (1, 4, 7) and three lamellar lipid bilayer phases will be discussed here, the liquid 
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crystalline phase, solid gel phase and the liquid ordered phase. The liquid crystalline phase is 
characterized by a low overall order parameter and rapid lipid diffusion in the bilayer (7). This 
phase is often seen in bilayers at higher temperatures that contain lipids with unsaturated 
hydrocarbon chains (7). The opposite of the liquid crystalline phase is the solid gel phase, which 
maintains a high order parameter and slow lipid diffusion in the bilayer and is common in 
membranes consisting of lipids with saturated hydrocarbon chains (7). Finally, membranes can 
take on a liquid ordered phase (7), which is characterized with a high order parameter with rapid 
lipid diffusion. This is most easily seen in lipid rafts and clustering events where the lipids are 
associated with interactions with protein and/or ions in solution. This causes the specific lipids to 
have a high order in the headgroups but the acyl chains remain dynamic. Interestingly, several 
different phases can be observed in a continuous bilayer allowing for various biological 
processes to take place across the entire membrane (1, 4, 7). As with their protein counterparts, 
investigations of the structure and dynamics of membranes will give insights into their biological 
processes. 
1.3 NMR as a Tool in Investigating Conformational Changes 
1.3.1 Overview 
NMR has evolved into a powerful method used to investigate the structural and dynamic 
properties of biological molecules. The first spectrum of a protein was recorded in 1957 (8) but it 
took 28 years to develop the techniques needed to solve the first NMR structure of the 57 residue 
bull seminal trypsin  inhibitor (9). NMR is now routinely used to solve structures of much larger 
systems, including membrane proteins and protein complexes. In addition to solving full 
structures, NMR data can be used in a number of ways to collect atomically resolved information 
on the structure and dynamics of biological molecules.  
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NMR can provide numerous insights into the structure and dynamics of proteins and other 
biological molecules without the calculation of a full structure by using chemical shifts, 
relaxation data, dipolar and scalar couplings. These observables can be obtained in a variety of 
spectra and can result in a plethora of information on torsion angles, hydrogen bonding, inter and 
intra molecular distances. This dissertation uses both solution NMR and magic angle spinning 
(MAS) solid-state NMR (SSNMR) in the investigation of several biological systems. 
Conformation and dynamic changes in these systems due to various interactions will be explored 
by analyzing chemical shifts, dipolar couplings and relaxation properties.  
1.3.2 Chemical Shifts 
The resonance frequency of a nuclear spin is dependent upon its electronic surroundings, also 
referred to as the chemical environment of the atom. Specifically this refers to the electron 
density around the nucleus that “shields” it from the applied magnetic field. A mathematical 
expression of this is: 
ω= -γ(1-σ )Bo.    (1) 
Where, Bo is the strength of the applied magnetic field, γ is the gyromagnetic ratio of the atom, ω 
is observed frequency and σ is the shielding constant (10). The chemical environment is denoted 
by the value of σ. Atoms that are in different chemical environments will display different 
chemical shifts in the NMR spectra. Atoms lacking significant electron density (low shielding) 
will have high chemical shift values and atoms with a high degree of electron density will have 
low chemical shift values. The chemical environment of a given atom is effected by several 
different factors such as, the ionic strength of the solution, covalent bonds and on structural 
arrangement (torsional angles of bonds).  
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Chemical shifts of amino acids in proteins contain a surplus of information about backbone 
and side-chain dihedral angles, hydrogen bonding, orientation of aromatic rings, ionization 
states, oxidation states and salt bridges (11). The chemical shift of individual spin system can be 
used to identify the amino acid type and, in concert with multidimensional correlation spectra, 
can be used to assign the chemical shifts to a specific amino acid within the protein sequence 
(10). After the chemical shifts have been indentified to match a particular amino acid in the 
protein sequence then those values can be interpreted and yield site-specific conformational and 
chemically relevant information.  
One such application is using the site-specific chemical shifts assignments of the protein to 
interpret the secondary structural elements (12-14). As stated previously, the chemical shifts are 
highly dependent on structure. The dihedral angles of the backbone atoms (Hα, HN, N, Cα, Cβ, 
CO) determine the secondary structure in proteins. Chemical shifts of the backbone atoms are 
compared to the expected random coil chemical shift (chemical shift of the atom when the amino 
acid is in a dynamic unstructured state). Deviations from the random coil chemical shift are 
indicative of the secondary structure (12-14).  Wishart and Sykes developed a tool known as the 
Chemical Shift index (14) that scores the chemical shifts based on their difference from the 
random coil value. Then, the output predicts the secondary structure as α-helical, β-strand or 
random coil. More recently an empirical program was developed to supply torsion angle values 
based on the chemical shift data; the most updated version is known as TALOS+ (15). Output 
from TALOS+ is based on a comparison of the chemical shifts with empirical data on proteins 
with known structures and chemical shifts (15). The values produced by TALOS+ are often used 
in structure calculations. Chemical shifts are therefore, a powerful tool in determining the 
structure of proteins. 
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Additionally, perturbations in chemical shifts can be use to investigate changes in the protein 
secondary structure upon interactions with other molecules. These interactions will lead to a 
change in the chemical environment, either through formation of new interactions (i.e. covalent, 
hydrogen bonds, salt bridges etc.), through conformational changes or both. Chemical shift 
perturbation mapping is used in solution NMR to map the interface of protein interactions (16). 
Basically, an unlabeled binding partner (either a small molecule, another protein, membranes 
etc.) is titrated into an isotopically labeled (at least 15N labeling) protein and 1H-15N HSQC 
spectra are acquired for each titration step. The chemical shifts of the amides are monitored for 
changes from the 1H-15N HSQC spectra of the protein in the absence of the binding partner. If 
any changes in an amide resonance are noted, they are “mapped” as the concentration of the 
binding partner increases (16). These changes can then be attributed to specific residues in the 
protein sequence. This reveals, with atomic resolution, the areas of the protein involved in the 
interaction. A similar approach can be used with SSNMR as well. By comparing unbound and 
bound spectra, changes in the chemical shifts can be noted and an interface of the interaction can 
be mapped onto the protein structure and/or sequence.  
1.3.3 Dipolar Couplings 
Dipolar couplings arise when two dipoles are fixed in space relative to one another and to the 
relative magnetic field (10). In solution NMR dipolar interactions are normally not taken into 
consideration (except in special cases, such as Residual Dipolar Coupling measurements) 
because in most cases the tumbling of the molecule averages the dipolar couplings to zero. In 
static SSNMR the dipolar couplings are not averaged to zero and the magnitude of the coupling 
(DIS) is dependent on orientation of the dipole vectors relative to the magnetic field (θ) and to the 
distance between the two spins (rIS) (10), 
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DIS =
γ Iγ S
4πrIS3
[1− 3cos2θ].  (2) 
Where γI is the gyromagnetic ratio of the I spin and γS, the gyromagnetic spin of the S spin. In 
MAS SSNMR the dipolar couplings are averaged to zero by spinning rapidly at the magic angle 
(54.7°), mimicking the tumbling in solution and making [1-3cos2θ]≈0. The dipolar couplings can 
be “recoupled” in SSNMR through a series of designed pulse sequences (17-19). Since the 
dipolar interactions are proportional to 1/rIS3, cross peaks in SSNMR spectra contain inherent 
distance information. This is taken advantage of and used to determine inter and intra molecular 
distances. Several specific pulse sequences that take advantage of homonuclear (DARR (17, 18)) 
and heteronuclear (TEDOR (19)) dipolar interactions and are used later on in the dissertation.  
1.3.4 Dynamics 
Biological molecules can undergo large fluctuations due to collision with solvent molecules, 
hinge-bending motions between secondary or tertiary structural elements and other relevant 
processes. The dynamics within a given biological molecule are linked to its interactions with the 
environment and other molecules. These molecular motions can cover a wide range of 
timescales. NMR has a unique capability to investigate a range of dynamic processes from the 
picosecond to the millisecond time scale (10) and therefore is perfect for investigating these 
important dynamical processes.  
Dynamic measurements in NMR investigate the relaxation of the magnetization for a given 
atom. Two main relaxation rates focused on in the following NMR experiments are the 
longitudinal-relaxation and the transverse-relaxation (10). Longitudinal-relaxation, sometimes 
referred to as spin-lattice relaxation, (T1) is described as the time it takes to return to the ground 
state after excitation (10). Transverse-relaxation, sometimes referred to as spin-spin relaxation, 
(T2) is described as the time required for loss of the magnetization in the transverse dimension 
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(10). T1 is dominated by interactions with the environment, while T2 is dominated by interactions 
with neighboring atoms. Simple experiments can be used to determine T1 and T2 where the 
intensity of the signal is measured as a function of the relaxation delay (10). Measuring these 
relaxation parameters gives insight into how the molecule interacts with itself and within the 
environment. Changes to the dynamics upon interactions with other molecules are another way 
to probe the conformational changes and give atomically resolved insight into the system.  
1.4 Systems Studied 
1.4.1 Alpha-synuclein and Endosulfine-alpha 
 
Figure 1.1 Structure of alpha-synuclein bound to micelles. 
The structure of AS was solved by solution NMR was solved bound to micelles made of sodium dodecyl 
sulfate (PDB 1XQ8) (20).  
Alpha-synuclein (AS) is an intrinsically unstructured protein in aqueous solution that is most 
notably associated with inherited and sporadic Parkinson’s disease as the major fibril protein 
component of Lewy bodies (21). Lewy bodies are also seen in other neurological disorders 
including Alzheimer’s disease, Down’s syndrome and multiple system atrophy (22). In addition 
to identification of AS in Lewy bodies, studies showed AS as a putative synaptic vesicle protein 
(23) and as a gene regulated in zebra finch during the learning of songs (24) but the normal 
function of AS is not yet well understood. 
The N-terminus of AS undergoes a conformational change in the presence of acidic 
phospholipid vesicles to a predominantly helical structure mediating membrane binding (20, 25-
27) (Figure 1.1). The structure is maintained through interactions with lysine side-chains and 
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negatively charged headgroups of the lipids (20). This allows the remaining hydrophilic residues 
to face outward towards the cytosol. Residues exposed to the cytosol are highly conserved (24), 
suggesting the membrane association of AS plays an important biological functional. Identifying 
binding partners with membrane bound AS would help to understand the biological function of 
synuclein outside the formation of the β-sheet-rich fibrils found in various neurological diseases. 
Chapter 3 looks into neurological proteins that interact specifically with membrane bound AS 
and NMR conformational investigations focus on a family of cAMP-regulated phosphoproteins, 
ARPP-19, ARPP-16 and endosulfine-alpha.  
Endosulfine-alpha (ENSA) was originally indentified as a protein involved in regulation of 
insulin secretion. Purified as an endogenous regulator for the ATP-sensitive potassium (K-ATP) 
channel (28), ENSA competes with the sulfonylurea glibenclamide for the sulfonylurea receptor 
(SUR) subunits, a binding site in the β cell membrane on K-ATP channels (29). ENSA was 
shown to inhibit potassium conductance in reconstituted K-ATP channels when applied to the 
intracellular side of the membrane (30). K-ATP channels are metabolic sensors for various cell 
types and play a central role in regulating insulin secretion (31). Inhibition of K+ currents in K-
ATP channels causes membrane depolarization and activation of voltage-gated Ca2+ channels, 
triggering insulin release. These same channels mediate glucose-stimulated insulin secretion, as 
they are inhibited and activated by metabolically produced ATP and MgADP. On that basis it 
was proposed that ENSA might be a natural regulator of insulin secretion and functional studies 
in Drosophila are consistent with such a role (32).  
ENSA may also play a role in neurological regulatory processes. In brain tissue, K-ATP 
channel closure is associated with neurotransmitter release (33) and has been implicated in the 
differential vulnerability of midbrain dopamine neurons to neurodegeneration in Parkinson’s 
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disease (34) leading to suggestions that sulfonylurea be considered as a candidate therapy for PD 
(35). Decreased expression of ENSA in the frontal cortex and cerebellum of Alzheimer’s patients 
(36) and in Down’s syndrome patients with Alzheimer’s disease pathology (37) indicates that 
ENSA’s expression varies significantly in several functional contexts.  Other functional studies 
show ENSA mRNA is down regulated in rat hippocampus with long-term memory 
consolidation, but up-regulated with swimming-related stress (38). ENSA’s aforementioned 
interaction with AS and, interactions with the membranes could play a key role in understanding 
its function in brain biochemistry. 
The NMR investigations presented in chapter 4 provide the first structural information for 
ENSA. Intrinsically unstructured in aqueous solution, ENSA forms a four helical sections upon 
interaction with membranes that contain negatively charged headgroups. Phosphorylation is a 
common mechanism for regulation of protein interactions, and it is known that protein kinase A 
phosphorylates S109 of ENSA (39). The role of the phosphorylation on the membrane-bound 
structure of ENSA using the S109E mutant is evaluated in chapter 5 As well interactions 
between AS and ENSA on the membrane surface.  
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1.4.2 Blood Coagulation: Tissue Factor 
 
Figure 1.2 Blood-clotting cascade. 
The extrinsic pathway to blood clotting initiates with the formation of the TF:FVIIa complex. TF:FVIIa 
activates FX and FIX and FIXa can also activate FX. FXa binds with activated FV forming the 
prothrombinase complex. From there thrombin is generated and the cascade continues to form a fibrin 
clot. 
Thrombotic diseases are a major cause of disability and death in the United States and 
worldwide. Improved prevention, diagnosis, and treatment have been made possible due to 
insights into the biochemical mechanisms of blood coagulation. More research is needed in this 
area to help further the medical knowledge and lower the mortality and disability rates. 
Almost every step in the blood-clotting cascade (Figure 1.2) involves the assembly of a 
serine protease with its cognate accessory protein on a suitable membrane surface.  Clotting is 
initiated when activated plasma factor VII (FVIIa) binds to the integral membrane protein, tissue 
factor (TF), forming an enzymatic complex on the membrane surface (40). The TF:FVIIa 
complex binds and activates its substrates, both factor X (FX) and factor IX (FIX). Activated 
FIX can in turn, also produce activated FX (FXa). Then, FXa forms the prothrombinase complex 
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on the membrane surface with activated factor V. This in turn converts prothrombin to thrombin, 
which propagates the coagulation cycle and ultimately ends in the formation of a fibrin clot. 
Composed of two fibronectin type III domains (extracellular domain), a cytoplasmic domain 
and a membrane spanning helix, (41) TF, the integral membrane protein involved in initiation of 
blood coagulation, is found on the surface of a variety of cells outside the vasculature (42). 
Factor VII (FVII) is a plasma serine protease and is the ligand for TF. A little less than 1% of 
FVII circulates in its active form (FVIIa) with the majority circulating in the zymogen form (43). 
FVII and FVIIa bind to TF with similar affinities (44) and once bound to TF, FVII is rapidly 
converted to FVIIa. The resulting enzymatic complex contains an essential regulatory subunit, 
TF and the catalytic subunit, FVIIa. It is well understood that TF induces conformational 
changes in the FVIIa active site, which dramatically increases activity (45-47). How TF 
dramatically enhances the enzymatic activity of FVIIa is not completely understood (48), 
although; membrane-anchoring of TF is absolutely required for full procoagulant activity (49). 
Allosteric activation of FVIIa upon binding to TF can be broken down into three 
components, proper positioning of the protease domain with respect to substrates, formation of 
the substrate binding site and induced conformational changes in FVIIa active site (50). Crystal 
structures solved for the soluble extracellular domain of TF (sTF) (51-53) and of sTF in complex 
with FVIIa (54, 55) (Figure 1.3) along with several other studies (56-60) have given insights into 
these interactions. Binding to TF positions the protease domain ~80 Å from the surface of the 
membrane (56, 57) allowing for the activation of its substrates. Residues from both TF and 
FVIIa form the proposed substrate-binding site. Several studies have located key residues in TF 
involved in the substrate-binding site, specifically K165 and K166 (58, 61-63) (Figure 1.3). The 
most intriguing component to the allosteric activation is the conformational changes in FVIIa’s 
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active site by distant contacts of TF with the heavy chain of FVIIa (contains the active site). 
Several studies (reviewed here: (50)) investigate this interaction yet questions still remain. 
 
Figure 1.3 Crystal structure of sTF:FVIIa complex. 
The sTF:FVIIa complex is shown (1DAN (54)) with FVIIa (gray, space-filling) behind sTF (blue, 
cartoon). Drawn in red, space-filling model on sTF are K165 and K166, residues involved in the binding 
of FX and FIX. The red dotted lines indicate residues that are missing in the crystal data. 
Structural and atomically resolved dynamic information is not currently available for key 
residues in TF involved in the allosteric activation of FVIIa. TF Residue E91 is important for 
binding to FVIIa and for converting FIX to FIXa (64) and recent studies report dynamic changes 
in a loop containing E91, residues 79 to 92, upon binding to FVIIa (65). Though this dynamic 
data is important, it is low resolution and these interactions are missing in the crystal structures 
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of the sTF:FVIIa complex (54, 55) due to either lack of electron density or residues 
enzymatically removed prior to crystallization (Figure 1.3).  
In addition, the substrate-binding site of the TF:FVIIa complex is located near the membrane 
surface and current complex structures lack any membrane interactions. Moreover, residues that 
are likely to interact with the membrane surface and effect the conformation of the substrate-
binding site are missing in the sTF:FVIIa complex. Figure 1.4 demonstrates this and shows 
K166, known to be crucial in the binding of substrate (58), in different conformations  in two 
sTF:FVIIa complex structures (54, 55). Chapters 8 and 9 focus on the assignment of chemical 
shifts of sTF and membrane bound TF (membTF) using both solution and solid-state NMR. 
Preliminary data on membrane bound TF reports on interactions between the membrane surface 
and several residues in the extracellular domain of TF.  
 
Figure 1.4 Substrate binding site of sTF:FVIIa complex. 
The substrate binding domain of the sTF:FVIIa complex is shown for crystal structure (a) 2A2Q (55) and 
(b) 1DAN (54). The light chain of FVIIa (bonds) is shown and is behind the sTF molecule (space filling). 
The highly conserved K166 residue, that is important for binding substrate, is highlighted in red on sTF. 
The two crystal structures show two very different conformations. The dotted red lines indicated residues 
missing in the crystal structures. The proposed location of the membrane is shown (red box). 
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1.4.3 Blood Coagulation: Ca2+ induced clustering of Phosphatidylserine 
There are many side effects and setbacks to using the available oral anticoagulant drugs 
(warfarin/coumadin) (66). In addition to their effect on proteins involved with blood clotting, 
coumadins also affect proteins involved in bone metabolism (67, 68). Other concerns include the 
narrow therapeutic range of Coumadin and Coumadin-like compounds and their unfortunate 
interactions with other drugs and the patient’s diet (66). A better drug designed with higher 
precision and specificity to blood coagulation would benefit patients with thrombotic diseases.  
Coumadins effect coagulation by preventing the proper formation of the membrane-binding 
domain of important blood clotting proteins. Several blood coagulation proteins (FVII, FIX, FX, 
prothrombin) share a common membrane-binding domain that is rich in γ-carboxylated 
glutamates (known as GLA domains). Coumadins are vitamin K antagonists and thus interfere 
with the cyclic interconversion of vitamin K and vitamin K epoxide (66). This cycling of vitamin 
K is essential for the γ-carboxylation of the glutamates in the GLA domain of coagulation factors 
(as well as several other GLA containing proteins involved in bone metabolism (67, 68)).  
Preventing these blood-clotting proteins from binding to membranes by hindering the production 
of functional GLA domains reduces their enzymatic activities many thousand-fold (69, 70). For 
example, FIX and FX are poorly activated by free FVIIa and experience a factor of 106 increase 
in activation when FVIIa is bound to TF in an appropriate phospholipid bilayer (71-73). The 
binding of the GLA domain to membrane surfaces is dependent on the presence of Ca2+ and 
anionic phospholipids, of which phosphatidylserine (PS) is preferred.  
We hypothesize that, in addition to the GLA domains of the blood coagulation proteins, 
specific conformational changes in the membrane bilayer is also required for effective blood 
coagulation. Specifically, Ca2+-induced PS clustering in membrane bilayers is a major factor 
  17 
involved in blood clotting. Calcium induces the formation of PS clusters in membranes (74). The 
clustering of PS is thought to act as target regions that enhance blood coagulation as well as 
other biological activities such as, Ca2+-triggered vesicle fusion (75) and protein kinase C 
signaling (76). Previous NMR studies have shown that Ca2+-PS interactions in mixed bilayers 
produces two distinct conformations in PS headgroups (77, 78), Additionally, bulk membrane 
dynamic studies of Ca2+-induced PS clusters show a broad and slightly elevated liquid crystal to 
solid gel phase transition (79-81). Although the formation of the Ca2+-induced PS clusters 
generates changes in the structure and dynamics for both the entire membrane and individual PS 
molecules; most of the dynamics data focuses on bulk changes in the membrane bilayer and 
atomically resolved structures of PS headgroups exist only for individual PS molecules in 
dodecylphosphocholine micelles in the absence of Ca2+ (82).  A more detailed molecular picture 
of the structure and dynamics of the individual PS molecules bound to calcium, as well as an 
atomic resolution structure of the Ca2+-induced PS-cluster are needed to elucidate key blood 
coagulation processes. Chapter 6 focuses on investigating, with atomic specificity, PS 
conformations and the dynamic properties of Ca2+-induced PS clusters.   
1.5 Conclusion 
Both membranes and their associated proteins play a critical role in biological processes and 
their functions depend on their structural and dynamic properties. As these biological molecules 
carry out their function by interacting with various other molecules, they undergo changes in 
dynamics and conformation. Studying these changes will help to better understand important 
biological processes, allowing for new insights into their role in physiology.  
Using NMR throughout my investigations, I report on the conformational and dynamic 
changes of several important biological systems. The normal function of AS most certainly 
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involves the helical membrane bound form. In this thesis (Chapter 3) I describe interactions of 
several neurological proteins with membrane bound AS. This includes revealing atomic 
resolution changes on the structure of AS as it interacts with two cAMP-regulated 
phosphoproteins (ARPP-19 and ENSA). Chapter 4 shows for the first time, that ENSA is an 
intrinsically unstructured protein in aqueous solution that undergoes a conformational change 
upon binding to membranes. The effect phosphorylation of S109 has on ENSA in both 
membrane binding and interactions with AS are identified in chapter 6. Structural and 
conformational changes for both membranes and proteins involved in blood coagulation are 
investigated in chapters 6-8. Atomic resolved dynamics and structural information is detailed for 
Ca2+-induced PS clustering important in blood coagulation (chapter 6). The last chapters’ focus is 
on pertinent conformational changes of the extracellular domain of TF. The final chapter 
describes an interaction of a loop (160-163) in the extracellular domain of TF with the membrane 
surface that is directly next to critical residues (K165 and K166) involved in binding to FIX and 
FX. The details of this dissertation will assist in answering important questions about the 
neurological function of AS and ENSA, as well as giving insights into important details of blood 
coagulation.  
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 CHAPTER 2 
Experimental Methods and Materials 
2.1 Introduction 
Acquisition of NMR spectra on proteins and other biological macromolecules requires the 
preparation of isotopically labeled samples. This includes not only developing expression 
systems that produce milligram quantities of sample, but also preparing the sample for the NMR 
tube or rotor. The NMR preparation needs to be stable for extended periods of time and to 
maintain a biologically relevant state. This chapter will address materials and methods used 
throughout this document that otherwise would not be addressed in the experimental sections of 
the individual chapters.  
2.2 Protein Preparation and Purification 
Protein expression and purification protocols for the proteins studied in this thesis are 
documented in the subsequent chapters and will not be repeated here. This chapter is dedicated to 
subtleties in the stability and storage of the protein systems after purified products are produced. 
This will contain data about wild type endosulfine-α (ENSA), S109E ENSA phosphorylation 
mutant (S109E), and soluble tissue factor (sTF). Also included will be the preparation of the 
crystal trays for the production of sTF nanocrystals used for SSNMR. 
2.2.1 Wild Type Endosulfine-α 
ENSA samples prepared for solution NMR studies were unstable at high concentrations. 
Samples of ENSA prepared in 50 mM phosphate buffer, pH 7.5 with protein concentrations of 7-
13.5 mg/ml (0.5 to 1 mM) allowed for 6-10 days of data collection before visible white 
aggregates were observed. The ENSA aggregates could be detected in the 1H-15N HSQC NMR 
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spectra (Figure 1). Broadening of the linewidths and the appearance of new resonances in the 
spectra (Figure 1b) typified the formation of the ENSA aggregate. Aggregation was faster (~5-7 
days) in samples containing lipid mimetics (i.e. SDS, lyso-PG, DPC), the bound form of ENSA 
(see chapter 4).  
 
Figure 2.1 15N-1H 2D HSQC NMR spectra of ENSA; stability tests. 
ENSA bound to SDS micelles at 25 ºC.  (a) Spectrum taken the first day of sample preparation. (b) 
Spectrum of the same sample taken after 7 days of data collection. Circled are new resonances that appear 
in the spectrum after the formation of ENSA aggregates. All the spectra were acquired with 4 scans per 
row, 512 rows, processed with sine bell apodization and zero filled in each dimension. 
Through variation of protein concentration and sample buffer it was determined ENSA 
aggregation is faster in sample preps with low ionic strength and high ENSA concentrations (>5 
mg/ml). ENSA is more stable in low concentrations in buffers with high ionic strength. 
Therefore, ENSA samples were stored at 4°C in the hydrophobic interaction column (HIC) 
elution fractions, which contain high levels of ammonium sulfate. ENSA was stored in several 
HIC fractions keeping the concentration of ENSA low (<2 mg/ml, generally lower than 1 
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mg/ml). ENSA was stored in this condition for 1-2 months with no appreciable loss to 
aggregation.  
If further NMR studies are carried out on ENSA, changes in the NMR sample preparation 
could be investigated to produce samples with longer lifetimes. Changes in the pH or the ionic 
strength of the NMR sample buffers could lead to samples with extended lifetimes. Though, 
considerations need to be given to the biological relevance and the effect changes in pH and/or 
ionic strength might have on interactions with membranes and other proteins (i.e. α-synuclein).  
2.2.2 S109E: sample preparation for NMR studies 
S109E, the phosphorylated mutant of ENSA, produced NMR samples that were stable for 
extended period of times. Protein kinase A (PKA) can phosphorylate S109 of ENSA (1). The 
S109E sample mimics the phosphorylated state of ENSA. Solution S109E NMR samples were 
prepared identically to the wild type ENSA samples and had lifetimes of  >6 months. Further 
discussion of the specific effects of phosphorylation on ENSA membrane binding and 
interactions with other proteins will be discussed in chapter 5.  
2.3 Tissue Factor 
2.3.1 Soluble Tissue Factor: Propensity to form oligomers 
Preliminary evidence points to the formation of oligomers in high concentration sTF 
samples. One example of the propensity of sTF to form oligomers is from a publication on an 
sTF crystal structure where Huang et al. reported that one of the first sTF crystals were grown by 
accident in a NMR tube with ~80 mg/ml sTF concentration (2). The samples were grown in two 
days in an NMR tube containing 3.5 mM (~80 mg/ml) sTF at 5° C in a 20 mM phosphate buffer, 
pH 7.5 (2). In Figure 2.2, a sizing column run with ~20 mg of sTF shows three resolved sTF 
peaks. A sizing gel was run on a fraction of each peak and confirmed that the fractions collected 
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were sTF. The first peak at 71 ml was pure monomer. The peak at 61 ml contained an sTF-dimer 
and the peak at 42 ml contained an sTF-trimer. Sizing runs done with less than 10 mg of sTF 
eluted only monomer sTF at ~71 ml. Since formation of the larger sTF oligomers is a function of 
the sTF concentration, sTF protein sizing columns were subsequently run with less than 10 mg of 
sTF and stored at lower concentrations (<5 mg/ml). 
 
Figure 2.2 Sizing column and Gel of high concentrated sTF. 
High-resolution gel filtration chromatography (HiPrep 16/160 Sephacryl S-200, GE Biosciences) of 20 
mg of sTF was run at 4 °C, with a flow rate of 0.5 ml/minute. STF eluted over a 15 ml volume (29 
minutes) in three resolved peaks. Monomer sTF started to elute at approximately 66 ml (132 minutes). 
The sTF-trimer eluted at 42 ml (84 minutes) and the sTF-dimer at 61 ml (102 minutes). 
2.3.2 Soluble Tissue Factor: Solution NMR sample preparation 
Various sample conditions were tested for preparation of solution sTF NMR samples to slow 
the formation of sTF dimers and trimers and extend sample lifetimes. Original sTF solution 
NMR samples were prepared at ~1mM (~26 mg/ml) concentrations in a 50 mM phosphate buffer 
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at pH 7.5 and had short lifetimes (~4-5 days). The samples did not aggregate but, as previously 
mentioned, form larger oligomers. This can be seen in the NMR spectra as a loss of signal to 
noise as a function of time (Figure 2.3). The loss of signal to noise is due to the broadening of the 
resonances attributed to the slower correlation time of the larger oligomers. Sample buffers were 
tested with varying pH levels and ionic strengths. Specifically, phosphate buffers with pH values 
varying from 4.5 to 8.5 were tested with and without 0-100 mM NaCl. Sample lifetime was 
increased to ~10 days by preparing the sTF sample buffer with 50 mM phosphate, pH 6.5 and 50 
mM NaCl.  
 
Figure 2.3 Amide proton spectra of sTF. 
Loss of signal to noise over time can be seen in the 1H spectra of the sTF amide protons over several days. 
The spectra show the 1H spectra of the sTF amide protons at (a) time 0, (b) two days and (c) six days. All 
the spectra were acquired with 8 scans, 512 rows? processed with sine bell apodization and zero filled. 
2.3.3 Soluble Tissue Factor: Solid State NMR sample preparation 
Investigating varying levels of sTF concentration, PEG3350 and Li2SO4 produced a 
nanocrystalline preparation for SSNMR sTF samples. The choices of precipitants used in the 
nanocrystalline preps were based on the preparation of single crystals in rabbit sTF (3). 
Microcrystalline sTF is prepared in a solution containing ~1 mM sTF and 15% PEG3350. 
However, various other conditions produced microcrystals as well (Figure 2.4). The current 
preparation was chosen to maximize sTF content in the pellet and minimize salt content.  
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Figure 2.4 Crystal Tray sTF. 
Varying amounts of Li2SO4 and PEG 3350 were used to test precipitation conditions at varying sTF 
concentrations. In each cell, three droplets of sTF at 3, 6 and 12 mg/ml were tested. Li2SO4 started at 200 
µM and was decreased in the cells from left to right and PEG increased from 10% (w/v) to 40 % in the 
cells from top to bottom. The tray was monitored over several weeks and observations were made as to 
the presence of as microcrystals (MC), precipitation (prec), quasi-crystals (QC), phase separated (phase), 
clear liquid (clear) or a mix of precipitate and microcrystals (prec/MC). 
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CHAPTER 3 
Conformation-Specific Binding of Alpha-Synuclein to Novel Protein 
Partners Detected by Phage Display and NMR Spectroscopy 
3.1 Notes and Acknowledgements 
 This chapter was adapted from Wendy S. Woods, John M. Boettcher, Donghua H. Zhou, 
Kathryn D. Kloepper, Kevin L. Hartman, Daniel T. Ladror, Zhi Qi, Chad M. Rienstra, and Julia 
M. George, J. Biol. Chem. 2007, 282, 34555-34567. This work was supported by grants from the 
Branfman Family Foundation (to JMG), the National Institute on Aging (NIA R01 AG13762, to 
JMG), the American Parkinson Disease Association (to CMR) and Research Corporation Cottrell 
Scholars Award (to CMR). 
3.2 Abstract 
Alpha-synuclein (AS) is an intrinsically unstructured protein in aqueous solution but is 
capable of forming β-sheet-rich fibrils that accumulate as intracytoplasmic inclusions in 
Parkinson’s disease and certain other neurological disorders.  However, AS binding to 
phospholipid membranes leads to a distinct change in protein conformation, stabilizing an 
extended amphipathic α-helical domain reminiscent of the exchangeable apolipoproteins.  To 
better understand the significance of this conformational change, we devised a novel 
bacteriophage display screen to identify protein binding partners of helical AS and have 
identified 20 proteins with roles in diverse cellular processes related to membrane trafficking, ion 
channel modulation, redox metabolism, and gene regulation.  To verify that the screen identifies 
proteins with specificity for helical AS, we further characterized one of these candidates, 
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endosulfine alpha (ENSA), a small cAMP-regulated phosphoprotein implicated in the regulation 
of insulin secretion, but also expressed abundantly in brain.  We used solution NMR to probe the 
interaction between ENSA and AS on the surface of sodium dodecyl sulfate (SDS) micelles.  
Chemical shift perturbation mapping experiments indicate that ENSA interacts specifically with 
residues in the N-terminal helical domain of AS in the presence of SDS but not in aqueous buffer 
lacking SDS.  The ENSA-related protein ARPP-19 (cAMP-regulated phosphoprotein 19) also 
displays specific interactions with helical AS.  These results confirm that the helical N-terminus 
of AS can mediate specific interactions with other proteins, and suggest that membrane binding 
may regulate the physiological activity of AS in vivo. 
3.3 Introduction 
Alpha-synuclein (AS) is an abundant constituent of healthy brain tissue, but its normal 
function is not well understood. In recent years, AS has gained notice due to its association with 
both inherited and sporadic Parkinson’s disease (PD). Mutations in the AS protein sequence are 
associated with PD (1-3), as are gene duplication events leading to increased expression of the 
protein (4, 5).  AS is also the major fibrillar protein component of Lewy bodies (6), which are 
associated with both sporadic and inherited PD, as well as Alzheimer’s disease, Down’s 
syndrome, and multiple system atrophy (reviewed in (7)).  AS was originally identified in three 
different contexts: as a putative synaptic vesicle protein (8), as a component of protein 
aggregates in Alzheimer brain tissue (9), and as a gene regulated in the zebra finch song control 
circuit during the critical period for song learning (10).  More recent evidence suggests a role in 
modulating neurotransmission (11, 12).  
AS displays remarkable structural plasticity.  While the protein is intrinsically unstructured in 
aqueous solution, it can adopt multiple distinct stable conformations depending upon its 
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environment.  Upon prolonged incubation in aqueous solution, the protein forms amyloid fibrils 
rich in β-sheet secondary structure, reminiscent of the pathological fibrils found in Lewy bodies.  
However, in the presence of acidic phospholipid vesicles, the N-terminus of AS folds into an 
amphipathic helical conformation that mediates membrane binding (13-15).  The hydrophilic 
face of this helix, which is presumably exposed to the neuronal cytosol (16), is highly conserved 
at the level of individual amino acids (10), suggesting that interactions with other binding 
partners have constrained its evolution. 
Conventional methods for identifying protein binding partners in solution (e.g., 
immunoprecipitation, yeast two-hybrid screening) are unsuitable for study of interactions that 
depend on the helical conformation of AS.  Under intracellular conditions, AS appears to be in 
dynamic equilibrium between membrane and cytosol, and there is thus no practical way to enrich 
for a particular conformation in vivo. We therefore developed a novel in vitro approach utilizing 
bacteriophage display to screen for proteins that bind selectively to AS in its lipid-associated 
helical conformation.  Applying this method, we identified 20 human brain proteins that interact 
specifically with phospholipid-bound AS.  One of these proteins, endosulfine alpha (ENSA), was 
chosen for further investigation because its small size (13 kDa) is compatible with solution 
NMR.  To characterize the interaction between ENSA and AS in detail, we employed chemical 
shift perturbation mapping experiments that demonstrate a highly selective interaction between 
ENSA and specific residues in the N-terminal helical domain of AS.  This observation was 
extended by demonstration of a similar interaction between AS and cAMP-regulated 
phosphoprotein 19 (ARPP-19), a protein highly related to ENSA that is also enriched in brain.   
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3.4 Experimental Procedures 
3.4.1 Phage Display  
  N-terminally his-tagged human alpha-synuclein (AS) protein was expressed in E. coli 
via the vector pET28a (Novagen), and purified on Ni-NTA (Qiagen) according to manufacturer’s 
directions.  Phospholipid vesicles (3:1 POPC/POPA) were prepared according to published 
protocols (14, 17); our previous studies indicate that stabilization of the AS helical domain 
requires acidic phospholipids, and that helix content is specifically maximized by the inclusion 
of phosphatidic acid (13, 14).  75 µg his-AS was incubated with 1.5 mg vesicles, and 
protein/vesicle complexes were isolated on a Superose 6 size exclusion column (GE 
Biosciences).  Protein/vesicle complexes were incubated with T7 bacteriophage displaying 
cDNA from human brain (Novagen T7 Select). 1 X 107 pfu were incubated with 5 µg vesicle-
bound AS for 1 hour at RT.  Ni-NTA agarose beads (Qiagen) were added and the mixture was 
incubated end-over-end for 2 hours at 4ºC.  The suspension was poured into a column and the 
beads were washed with 20 mM imidazole to remove unbound phage, followed by phospholipid 
vesicles (protein-free) to elute phage with specificity for POPC/POPA vesicles.  Finally, 
bacteriophage that bound to membrane-bound AS were eluted by addition of purified AS/vesicle 
complexes.  The eluates were pooled and amplified in E. coli, then subjected to 3 more cycles of 
biopanning.  After the final round, the eluates were applied to an affinity column prepared with 
his-tagged AS alone, and the flow-through was collected, to select for phage that did not bind to 
unstructured (lipid-free) AS.  Individual bacteriophage clones were amplified and subjected to 
sequencing to identify the human brain protein sequences displayed by each. 
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3.4.2 Recombinant protein expression  
 Human endosulfine alpha (ENSA) was cloned from the full-length phage clone into the 
vector pDEST17 (Invitrogen), which encodes the N-terminal his-tagged linker 
MSYYHHHHHHLESTSLYKKA GSAAAPFT.  The ARPP-19 cDNA (Origene) was also 
cloned into pDEST17.  Recombinant protein expression was induced with 0.2% arabinose at 
30ºC for 3-4 hours (ENSA) and 5 hours (ARPP-19) and purified on Ni-NTA agarose (Qiagen) 
according to manufacturer’s directions.   
 An untagged ENSA construct was made in the vector pET21 (Novagen).  Protein was 
expressed by induction with 1mM IPTG at 30ºC, followed by alkaline lysis, boiling, and 
precipitation with 60% ammonium sulfate.  Precipitates were purified by hydrophobic interaction 
chromatography on a HiPrep 16/10 Butyl Fast Flow Sepharose column (GE Biosciences), and 
eluted with decreasing salt.  ENSA-containing fractions were pooled and concentrated, then 
subjected to high-resolution gel filtration chromatography (HiPrep 16/160 Sephacryl S-200, GE 
Biosciences).  Purity of recombinant ENSA, his-tagged ENSA, and his-tagged ARPP-19 proteins 
were confirmed by Coomassie staining. All proteins were shown to be immunoreactive with a 
chicken polyclonal antibody raised against full-length human ENSA (Abcam ab14297) (Figure 
7.1).  In addition, predicted molecular weights of recombinant proteins were verified by mass 
spectroscopy (data not shown). 
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Figure 3.1 Characterization of purified recombinant ENSA and ARPP-19 proteins. 
Purified proteins (his-tagged ARPP-19, his-tagged ENSA, and untagged ENSA) were separated by SDS-
PAGE, followed by (A) Coomassie staining for total protein or (B) immunoblot with a chicken polyclonal 
antibody raised against full-length human ENSA.  As expected from the similarity of these sequences, the 
antibody cross-reacts with ARPP-19. (Figure supplied by Wendy Woods and Dr. Julia George.) 
Full-length, untagged AS protein was produced for NMR experiments according to published 
procedures (18). For isotopically labeled protein, cultures were grown in M9 minimal media 
supplemented with 2 g [13C]-glucose, 1 g [15N]-ammonium chloride, 10 mg biotin, 10 mg 
thiamine and 10 mL [13C, 15N]-Bioexpress (Cambridge Isotopes Laboratories, Inc., Andover, 
MA). The final steps of the purification (size-exclusion chromatography and filtration (0.2 µm)) 
were performed immediately prior to NMR experiments, in order to avoid the presence of 
oligomeric species of AS.   
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3.4.3 NMR spectroscopy  
Solution NMR spectra were acquired at the VOICE NMR Facility on a Varian INOVA 600 
MHz spectrometer equipped with a 5 mm, triple resonance (1H-13C-15N) triaxial gradient probe, 
using VNMRJ version 2.1B with the BioPack suite of pulse programs released in early 2006.  2D 
1H-15N HSQC spectra were measured typically for two hours per spectrum, digitizing 512 
complex points in the indirect 15N dimension (t1max = 232 ms).  Further details specific to each 
spectrum are provided in the figure captions.  Spectra were processed with NMRPipe (19) and 
analyzed in Sparky (20), using the previously established assignments of 15N and 1H chemical 
shifts of AS in the free (21) and micelle-bound states (15, 22).  The free state consisted of 0.2 to 
0.5 mM 15N-labeled-AS in 50 mM phosphate buffer, pH 7.4, 10% D2O, and 0.1% DSS as an 
internal chemical shift reference. The micelle-bound state of AS was prepared by addition of 
sodium dodecyl sulfate (SDS) directly to the NMR tube, achieving a final concentration of at 
least 28 mM, i.e., a 140:1 molar ratio of SDS to AS, with the concentration of SDS significantly 
above its critical micelle concentration. The critical micelle concentration in 50 mM phosphate 
buffer at 25 °C was determined to be ~2 mM using isothermal titration calorimetry (ITC) (data 
not shown). In all NMR experiments, the 15N-AS sample was examined in the unfolded state to 
confirm sample integrity; subsequently, SDS was added to prepare the micelle-bound state, and 
natural abundance partner proteins were titrated immediately thereafter.  Control spectra of AS 
were highly reproducible and showed no evidence of aggregation, such as peak broadening, 
changes in chemical shifts as a function of time, or signal intensity losses. 
3.4.4 Partner protein titrations  
For each partner protein, two series of titration experiments were performed.  First, free 15N-
AS was prepared as described above and the control HSQC spectrum acquired.  To this 0.2 mM 
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AS solution (400 µL), ~40 µL aliquots of natural abundance partner protein (0.2 mM) were 
added.  HSQC spectra were acquired at each step, up to the point at which AS and the partner 
protein had equal concentrations.  Second, a fresh sample of 15N-AS was prepared in the micelle-
bound state, the control HSQC spectrum acquired, and titrations of the same partner protein 
(without additional SDS) performed over a range of AS to partner protein ratios of 1:0 to 1:1.  In 
a subset of the experiments, the order of addition was changed by first mixing the AS and partner 
protein in their free states and then adding an excess of SDS, and yet another case the partner 
protein (ENSA) was first bound to excess SDS before addition to the AS-SDS solution.  These 
procedures all resulted in HSQC spectra corresponding to the final step of the partner protein 
titration, which were identical to within the limit of statistical significance (~0.01 ppm).  The 
chemical shift perturbation integrating both changes in 1H and 15N chemical shifts was defined as 
δ = ([0.1 δN]2 + δH2)1/2, considering that the 15N shift covers a range ~10 times that of 1H. 
3.5 Results 
3.5.1 Binding partners of helical alpha-synuclein by phage display.   
Vesicle-bound AS was used to pan a human brain bacteriophage display library as described 
in Experimental Procedures.  After 3-5 rounds of selection, individual clones from the pool were 
amplified, and their inserts were determined by sequencing with primers flanking the insertion 
site in the gene encoding coat protein 10B.  338 bacteriophage clones were sequenced, of which 
38 yielded readable in-frame sequences of identified human brain proteins.  These 38 sequences 
represented 20 unique proteins, seven of which were isolated more than once and 13 that were 
single isolates.   
In Table 1, the candidates are sorted based upon the functional data available in the literature.  
Seven of these proteins have been reported previously to interact physically or functionally with 
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AS under various conditions.  These proteins include alpha-tubulin, the sequence isolated with 
the greatest frequency overall (6/38 bacteriophage clones). Our laboratory  
Table 3.1. Interactions with synuclein. 
Candidate human brain proteins that interact with helical alpha-synuclein, as identified by bacteriophage 
display. (Table supplied by Wendy Woods and Dr. Julia George.) 
Protein (synonyms) Uniprot 
accession # 
Function(s) # Isolates Prior report of 
AS interaction 
Cytoskeleton/vesicle trafficking 
α-Tubulin P68363 microbutule subunit 6 (23, 24) 
Septin 4 (Sept 4, cdc-rel2) O43236 cytoskeletal component 2 (26) 
Kinesin light chain 1S (KLC1S) Q07866-8 microtubule motor 3 (27) 
Dynein heavy chain 1 (DHC1) Q14204 microtubule motor 2 (27) 
Synapsin 1a P17600 actin binding, regulates 
presynaptic vesicle pools 
1  
Ectodermal neural cortex 1 
(ENC-1NRP/B) 
O14682 actin binding, regulates neuronal 
process formation 
4  
Ion channel modulation 
Endosulfine-α (ENSA) 043768 modulates K-ATP channels, L-
type Ca++ channels 
1  
Sorcin (SORCN) 
 
P30626 modulates K-ATP channels, L-
type Ca++ channels 
1  
Annexin A6 
 
 
P08133 modulates L-type Ca++ channels 1  
Redox metabolism 
R-β-hydroxybutyrate 
dehydrogenase, type 2 
cytosolic (BDH2) 
Q9BUT1 converts R-β-hydroxybutyrate to 
acetoacetate 
1  
Multifunctional enzyme 2 
(MFE2)  
P51659 fatty acid beta-oxidation, also 
reduces estradiol to estrone 
1  
Cytochrome C oxidase, 
subunit 1 (COX1) 
Q6RRI3 mitochondrial electron transport 1 (28) 
Peroxiredoxin 1 (PRDX1) Q06830 peroxidase, chaperone 1  
Transcriptional complexes     
Proline-, glutamic acid-, and 
leucine-rich protein 1 
(PELP1, MNAR) 
Q8IZL8 co-activator of estrogen receptor 
alpha, transcriptional co-
repressor 
1  
SAP30 binding protein 
(SAP30BP,HCNGP, HTRP) 
Q9UHR5 transcriptional co-repressor, 
possible component of histone 
deacetylase complex 
1  
FK506 binding protein 52 
(FKBP52) 
Q02790 chaperone, component of steroid 
receptor complexes 
4 (29) 
Heat shock cognate 70 
(Hsc70, HspA8) 
Q96IS6 chaperone, component of steroid 
receptor complexes, clathrin-
uncoating ATPase 
4  
Other     
Prefoldin 2 (PFDN2) Q9UHV9 folding chaperone 1  
Ubiquitin specific protease 47 
(USP47) 
Q96K76 ubiquitin specific protease 1  
G protein-coupled receptor 
kinase 2 (GRK2) 
P25098 G protein-coupled receptor 
desensitization 
1 (31, 74) 
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has previously reported that AS binds monomers of alpha- and beta-tubulin (23), and it was 
recently reported that AS binds monomeric tubulin and stimulates microtubule polymerization 
(24).  Like alpha-tubulin, septin 4 (also known as CDCrel-2) is a filament-forming G protein 
thought to function as a scaffolding protein for membrane/cytoskeleton interactions (reviewed in 
(25)); septin 4 was shown to bind AS when the two proteins are co-expressed in cultured cells, 
and to co-associate with AS in Lewy bodies (26).  Kinesin light chain 1S and dynein heavy chain 
I are components of microtobule motors critical for vesicular and organellar trafficking in 
neurons and other cells.  Our identification of these proteins confirms a previous report by Utton 
et al. that AS interacts with complexes containing either dynein or kinesin-1 in neurons (27).  As 
previously reported by Elkon et al. (28), we find that AS binds to cytochrome C oxidase, the 
mitochondrial complex IV enzyme. FK506 binding proteins, members of the immunophilin 
protein family, were recently reported to stimulate fibril formation by alpha-synuclein (29); one 
of these family members, FKBP52, was recovered in our screen. Of the remaining proteins in 
Table I, only G protein-coupled receptor kinase 2 (GRK2) has been reported to interact with AS 
in prior studies.  GRK2 phosphorylates AS at serine 129, a modification that enhances AS 
inclusion formation in cell culture (30) and in a Drosophila model of PD (31). 
The sizes of the cDNA inserts in the bacteriophage library vary, but generally encode no 
more than 200 amino acids of the corresponding human brain proteins.  This means that in many 
cases a protein domain sufficient for interaction with AS can be inferred from the sequence of 
the phage insert.  These preliminary “AS-binding domains” are mapped in Figure 2, along with 
known functional domains when available.  
For our present purpose, of greatest interest are the 13 interacting proteins identified for the 
first time in this screen. These may represent interactions that depend specifically on assumption 
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of a lipid-dependent helical structure. Each of these interactions is worthy of specific study; here 
we focus on detailed characterization of the interaction with endosulfine alpha (ENSA), the 
smallest protein in the set.  ENSA was originally described as an endogenous ligand for the 
sulfonylurea receptor SUR1 (32), a subunit of the ATP-sensitive K+ channel. ENSA is abundant 
in the brain, where its expression is downregulated in Alzheimer’s disease (33) and Down’s 
syndrome (34). 
 
Figure 3.2 Alignment of phage-displayed sequences with full-length human proteins.  
Sequences of bacteriophage inserts (solid rectangles) are aligned with the corresponding full-length 
human sequences (black lines).  Known functional domains in the full-length proteins are also depicted 
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for comparison (open rectangles).  Sequence lengths are drawn to scale, except as indicated by broken 
lines. (Figure supplied by Wendy Woods and Dr. Julia George.) 
3.5.2 NMR characterization of AS-ENSA interactions. 
NMR chemical shift perturbation mapping experiments were undertaken to determine the 
conformation dependence and structural specificity of the interactions between AS and ENSA.  
First, we tested for interactions between non-helical AS and ENSA.  15N-AS was prepared in 
aqueous buffer at ~0.5 mM concentration.  The 1H-15N HSQC spectrum was acquired and 
 
Figure 3.3 15N-HSQC NMR spectra of ENSA interacting with AS.   
This interaction requires an anionic micelle. (A) Spectrum of 0.5 mM free AS (red) overlaid with the 
spectrum of the sample after addition of ENSA in a 1:1 molar ratio (blue).  Both spectra were acquired at 
10° C. (B) Spectrum of a 0.5 mM AS sample with excess SDS (83 mM). The spectrum was acquired at 
25° C. (C) The same spectrum in (B) (red) overlaid with a spectrum of the sample with the addition of 
ENSA in a 1:1 molar ratio (blue). All spectra were acquired with 4 scans per row and 512 complex points 
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in the 15N dimension, and processed with sine bell apodization and zero filling prior to Fourier 
transformation. (D-F) Expanded regions of the spectrum demonstrating chemical shift perturbations of 
specific residues upon titration of SDS-bound AS with ENSA. Ratios of AS to ENSA are 1:0 (red), 1:0.4, 
(green) and 1:1.0 (blue). 
confirmed to be consistent with the unfolded state of AS as previously reported by Eliezer (15, 
35) (Fig. 3A). Superimposed on the spectrum of pure 15N-AS is the spectrum of 15N-AS with an 
equimolar quantity of ENSA.  The peak positions throughout the spectrum remain essentially 
unchanged, with the exception of a portion of the C-terminal domain of AS, where some changes 
on the order of 0.01 ppm were observed.  Elsewhere, changes in the spectra were within the 
random error of the chemical shift measurements (δ ~0.01 ppm).  Sources of uncertainty in the 
chemical shifts include slight changes in pH or buffer concentration; therefore all the protein 
solutions were prepared by dialysis against a common buffer solution to minimize such effects.  
Next, we evaluated the interaction between ENSA and helical AS. A fresh 15N-AS sample 
was prepared and SDS was added to create an excess number of detergent micelles, in the 
presence of which AS forms a stable, folded hairpin helical structure throughout the N-terminal 
~100 residues (36). The stoichiometric excess of SDS, as previously determined by Eliezer (15) 
and utilized in studies by Chandra (22) and Ulmer (22, 36), was confirmed in our experiments by 
titrating SDS into a solution of free AS.  We confirmed that the molar ratio of approximately 
70:1 SDS:AS was required to ensure that all AS molecules were micelle-bound. Addition of SDS 
beyond the 70:1 molar ratio causes only small changes, and in the range studied here for protein-
protein interactions, from ~100:1 to 200:1 SDS:AS ratio, there are no chemical shift 
perturbations of significance (>0.01 ppm; see Figure 4).  All of the subsequent titrations 
involving helical AS were carried out in molar ratios ≥ 140:1 SDS:AS, which is more than 
sufficient for complete binding of AS.  Moreover, a ~50% or greater excess of unpopulated 
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micelles remains available in the solution for binding to the candidate protein.  The spectrum of 
15N-AS on a micelle (Figure 3B) agrees well with published chemical shifts for 15N and 1H.   
When ENSA was then added, systematic and highly reproducible changes in the spectra 
occurred.  Fig. 3C illustrates the beginning and end points of the ENSA titration, where the 
chemical shift perturbation is most easily identified.  The signals fall into three categories.  First, 
many signals show substantial changes in chemical shift, i.e., the peak positions change by 
significantly more than the total peak line width.  For example, A19, E20, T44, G51, A69, V71, 
and V74 are residues that show such unambiguous changes.  Second, many other resonances 
show smaller shifts between 0.05 and 0.10 ppm δN; examples include K12, T14, A30, V49, A56, 
T81 and A89. Finally, dozens of peaks (such as A17, E13, Q24, G25 and T75) shift by less than 
0.05 ppm in the 15N dimension but still significantly more than the random error in the 
measurements. 
Fig. 3D-F shows the chemical shift changes systematically as a function of ENSA 
concentration.  The progression of peak positions from the initial to final state is continuous and 
approximately linear with the ENSA concentration.  For example, the G67 (Fig. 3E) resonance 
moves down (downfield in 15N) and to the right (upfield in 1H) by more than 0.1 ppm δN.  A69 
(Fig. 3D) changes most significantly in the 1H dimension.  In other regions of the spectrum, 
several resonances such as A27, G73 and V74 (Fig. 3D, E, F) show a similar pattern.  Other 
resonances move by smaller total amounts, but typically in a linear manner with concentration.   
At no point in the titration of ENSA were multiple peaks observed for a given AS amide 1H-
15N site.  This is consistent with a fast chemical exchange process, in which there is an 
interconversion between (1) the micelle-bound state of AS and (2) the micelle-bound state of AS 
in complex with the micelle-bound state of ENSA. (Several biophysical methods, including 
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NMR (37), isothermal titration calorimetry (ITC), and circular dichroism (CD) spectroscopy 
(Boettcher et al., unpublished data) demonstrate strong binding of ENSA to SDS micelles, 
accompanied by a substantial change in secondary structure).  If this process were slow 
(exchange rates of much less than 1,000 s-1), each molecule would be either in state 1 or 2 during 
the course of the NMR acquisition, and two signals would be observed for each residue.  Instead, 
characteristic of the fast exchange process (rates much greater than ~1,000 s-1), the weighted 
average of the chemical shifts of the states 1 and 2 is observed.  The exact peak position 
therefore depends upon the populations of states 1 and 2 (38, 39); the population of state 2 
gradually increases throughout the titration, and therefore the peak gradually moves in this 
direction. 
In Fig. 4 the chemical shift perturbations are plotted as a function of residue number.  Fig. 4A 
illustrates the very small effects of adding ENSA to a solution of AS in the absence of  
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Figure 3.4 Chemical shift perturbations upon titration of AS with ENSA.  
The perturbations (δ = ([0.1δN]2 + δH2)1/2) were calculated for well-resolved sites in the 2D HSQC spectra. 
(A) Perturbations of free AS by the addition of ENSA at 1:1 molar ratio. (B) Perturbations of SDS-bound 
AS by the addition of ENSA at 1:1 ratio 
SDS. We interpret this as corresponding to no observable change in structure and minimal 
interaction between the unfolded proteins (primarily in the C-terminus of AS).  Fig. 4B illustrates 
the corresponding shifts observed, for the end point of the titration, in the presence of SDS.  In 
this case, large chemical shifts are observed in many positions throughout AS, including many 
prominent shifts throughout the N-terminal domain, which are not seen at all in the unfolded 
state.  Analysis of 15N T2 relaxation (Table II) is consistent with a population of SDS-AS-ENSA 
ternary complex that is larger than the SDS-AS binary complex. The transverse relaxation times 
were measured from the 15N linewidths of HSQC spectra on AS in three different states (free in 
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solution, bound to SDS micelles, and in the SDS-AS-ENSA complex), and the correlation time 
computed assuming an isotropic tumbling model under standard conditions (75). 
Table 3.2. Results of the 15N linewidth analysis.  
For each state three different spectra were analyzed and the averages and standard deviations are reported. 
In all states C-terminal residues 90 to 140 are unbound and these residues were excluded from the 
analysis.  T2 is the transverse relaxation time constant, R2 is equal to the inverse of T2 and τc is the 
calculated correlation time. 
 
 
 
 
 
3.5.3 Common AS-binding domain in ARPP family proteins. 
ENSA is a member of the cAMP-regulated phosphoprotein family, which also includes 
cAMP-regulated phosphoproteins ARPP-16 and ARPP-19.  ARPP-16/19 are differentially 
spliced products of the same gene, found at the chromosomal locus 15q21.2 in humans (Unigene 
Hs.512908, (40)), and are identical except for their extreme N-termini.  ENSA is the product of a 
distinct gene at the locus 1q21(41), which also differs from ARPP-16/19 primarily at the N-
terminus.  A central domain of 66 amino acids is highly conserved among ENSA and ARPP-
16/19 (Fig. 5), suggesting that these proteins might interact similarly with helical AS.  To test 
this hypothesis, recombinant his-tagged ARPP-19 was prepared, and its interactions with AS 
were assessed by solution NMR. 
 
 
Sample T2 (ms) R2 (s-1) τc (ns) 
Free AS 51.2±1.8 19.8±0.7 10.5±0.4 
SDS-AS 35.7±1.0 28.0±0.8 15.2±0.4 
SDS-AS-
ENSA 
32.5±0.7 30.8±0.7 16.8±0.4 
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Figure 3.5 Alignment of the amino acid sequence of ENSA with ARPP-16 and 19. 
ARPP-16 and –19 are differentially spliced products of the same gene, and differ only at their N-termini.  
Boxed residues are identical among the sequences. The conserved PKA phosphorylation site is indicated 
(*). (Figure supplied by Wendy Woods and Dr. Julia George.) 
The NMR data illustrate the qualitatively similar behavior of AS when titrated with ARPP-19 
as when titrated with ENSA.  AS shows no substantial changes in the spectra when AS and 
ARPP-19 are combined in free aqueous solution; the spectra of 15N-AS, with and without a 
stoichiometric equivalent of ARPP-19 in the solution, are essentially identical within 
experimental error.  No 15N chemical shifts vary by more than 0.02 ppm.  Figure 6 illustrates 
changes from the starting point of the SDS micelle-bound AS sample, as ARPP-19 is added.  
Throughout the ARPP-19 titration, many of the same features in the spectra of 15N-labeled AS 
are observed as in the aforementioned ENSA titration experiments.  Common observations 
include: (1) the chemical shift changes are systematically observed at many sites throughout the 
molecule;  
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Figure 3.6 15N-HSQC NMR spectra of AS interacting with ARPP-19. 
Spectrum of 0.5 mM 15N-AS sample with excess SDS (83 mM) (red) is overlaid with the spectrum of the 
sample after the addition of ARPP-19 in a 1:1 molar ratio (blue). The spectra were acquired at 25° C, with 
4 scans per row and 512 complex points in the 15N dimension, and processed with sine bell apodization 
and a single zero fill. 
(2) the changes are approximately linear with partner protein concentration; (3) at no time are 
multiple resonances observed for an individual AS residue.  Plotting the chemical shift changes 
as a function of residue number (Fig. 7) illustrates significant shifts throughout AS in the 
presence of SDS.  As with the plot of ENSA data in the same format (Fig. 4), a qualitatively 
similar pattern of changes is observed in the N-terminal domain.  The major difference observed 
for the titration of SDS micelle-bound AS with ARPP-19 (which bears an N-terminal his-tag) as 
compared to ENSA (which is untagged) is the presence of chemical shift perturbations >0.02 
ppm in the C-terminal 45 amino acids.  Similar C-terminal perturbations were observed in 
control experiments when SDS-bound AS was titrated with his-tagged ENSA (data not shown), 
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suggesting that these perturbations result from a secondary electrostatic interaction between the 
basic his-tag and the acidic C-terminus of AS. 
 
Figure 3.7 Chemical shift perturbations of AS upon titration with ARPP-19. 
(A) Perturbations with the absence of SDS. (B) Perturbations in the presence of excess SDS. The 
perturbations were calculated (δ = ([0.1δN]2 + δH2)1/2) for well-resolved sites in the 2D HSQC spectra. 
3.5.4 AS and ENSA do not simply compete for binding to micelles. 
The final NMR titration experiments were performed starting with stoichiometric equivalents 
of 15N-AS and natural abundance ENSA in aqueous buffer, titrating with increments of 35 
equivalents of SDS per titration point (Fig. 8).  The control spectrum (not shown) with no SDS 
reproduces the experiment shown in Fig. 3A.  The first titration point, at a stoichiometry of 
35:1:1 SDS:AS:ENSA, corresponds to one-half micelle for every two protein molecules.  All 
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signals corresponding to backbone amide sites in the first ~95 residues of AS are suppressed 
below the limit of detection sensitivity, due either to the long global correlation times of the 
micelle occupied by several protein molecules or chemical exchange among multiple micelle- 
 
Figure 3.8 15N-HSQC NMR spectra of labeled AS in a 1:1 molar ratio with ENSA. 
15N-HSQC NMR spectra of labeled AS in a 1:1 molar ratio with unlabeled ENSA titrated with SDS. 
SDS:AS:ENSA ratio is (A) 35:1:1, (B) 70:1:1, (C) 105:1:1, (D) 140:1:1, (E) 170:1:1, (F) 280:1:1. All 
spectra were acquired at 25° C, with 4 scans per row and 1024 complex points in the 15N dimension, 
processed with sine bell apodization, 3 Hz of Gaussian line broadening in the indirect dimension, a single 
zero-fill for both dimensions. 
populated species.  Only signals in the C-terminal domain of AS (including A107, Q109, 
G111, D119, S129 and A140), as well as the sidechain Asx and Glx signals, are observed under 
these conditions; these same signals are observed in solution NMR spectra of AS bound to small 
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unilamellar vesicles (15), owing to the flexibility of this domain (i.e., its rapid domain motion on 
the NMR timescale).  The N-terminal residues bound to the micelle are, however, broadened 
beyond detection and only begin to be observed at the ratio of 70:1:1 SDS:AS:ENSA (Fig. 8B).  
At this point, with approximately one micelle for every two proteins, a small population of 
micelles with only one AS is observed; these signals begin to emerge with significant sensitivity 
as the number of micelles with one bound protein increases (i.e., at 1.5 micelles, or 105 
molecules of SDS, for each AS-ENSA pair, Fig. 8C).  Signals that arise over this range of the 
titration include many readily assigned to the N-terminal domain of AS, such as K10, A19, K32, 
E46, G51, T44, A56, G67 and V74.  As the number of micelles approaches the number of 
proteins (Fig. 8D), the intensity of the AS N-terminal domain signals reaches a plateau, 
corresponding to an equilibrium population in the limit of excess SDS (Fig. 8D). Addition of 
further SDS (Figs. 8E and 8F) yields no further changes in peak positions or (beyond the dilution 
factor) peak intensity.  
3.6 Discussion 
3.6.1 Enrichment for conformation-dependent binding partners of alpha-synuclein 
We conducted a screen for proteins that interact specifically with the helical conformation of 
AS, and identified 20 candidate proteins, including 7 proteins previously reported to interact 
physically or functionally with AS, and 13 novel partners.  Using solution NMR, we performed a 
rigorous validation of the conformation-specific interaction of AS with one of these novel 
proteins, ENSA.  Our results provide further insight into the potential physiological function of 
AS and support the hypothesis that AS is sensitive to local environments within the cell and may 
modulate its interactions with diverse protein partners according to these environments.   
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We applied a two-stage screening study to select for interactions that occur only in the 
presence of lipids.  In the first phase, we selected for binding partners of membrane-bound alpha-
synuclein, a complex including both the helical N-terminus and the relatively unstructured C-
terminus.  This was followed by a subtractive step to select against binding partners that bound 
to lipid-free synuclein.  Thus our approach should have enriched for conformation-dependent 
binding partners, but might not have rigorously excluded proteins that interact with the C-
terminus, depending on the efficacy of the subtractive step. Indeed, two of the proteins identified 
in this screen (α-tubulin and cytochrome C oxidase) have been previously reported to interact 
with lipid-free AS (23, 24, 28).  To specifically validate the conformation-dependence of 
interactions we used solution NMR experiments, as discussed below. 
Our results confirm previous reports that AS interacts with elements of the cytoskeleton, 
especially microtubules and their associated motor proteins (23, 24, 27).  However, an interesting 
candidate emerged from this category: synapsin 1a, which to our knowledge has never been 
reported to bind AS. Synapsin and AS share intriguing similarities.  Both associate reversibly 
with presynaptic vesicles, and are thought to influence the activity-dependent recruitment of a 
reserve pool of vesicles to the readily-releasable pool (12, 42). The specific sequence isolated 
from our bacteriophage screen corresponds to domain E of synapsin 1a (Figure 3.2), a region 
specifically implicated in this process (43, 44).   
Four candidates in Table I participate in various transcriptional complexes.  The name 
“synuclein” is derived from the early report of its localization to both synapses and nuclei (8), 
and several recent studies confirm its nuclear localization (45, 46), where it is found to interact 
with histones and to inhibit histone acetylation.  Indeed, another synuclein protein family 
member, gamma-synuclein, has been reported to function as a chaperone for estrogen receptor-
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alpha, stimulating ligand binding and activation of the receptor (47).  While the conformation 
dependence of AS interactions with these partners remains to be determined, the potential 
association of AS with nuclear receptor complexes is intriguing. 
Four additional candidates have functions related to redox metabolism. These AS/partner 
protein interactions may be of particular interest in AS pathology, as PD pathogenesis is strongly 
linked to mitochondrial dysfunction and oxidative stress.  As previously reported by Elkon et al. 
(28), we find that AS binds to cytochrome C oxidase, the mitochondrial complex IV enzyme.  
We also observe a novel interaction with a newly identified type 2 cytosolic R-β-
hydroxybutyrate dehydrogenase (BDH2). Its substrate R-β-hydroxybutyrate is beneficial in 
alleviating mitochondrial inhibition and oxidative stress in several animal models of PD (48-50), 
so intracellular regulation of its metabolism by AS is potentially very significant.   
Three of the candidate proteins identified in this screen, sorcin(51), annexin A6(52), and 
endosulfine alpha(53), have been reported to directly modulate the activities of ion channels. 
These observations suggest a role for AS in modulation of neuronal excitability, interesting 
because AS has been reported to negatively regulate neurotransmission (11, 12). Endosulfine 
alpha (ENSA) was originally identified as an endogenous regulator of K-ATP channels (32), 
although this potential function remains controversial (54, 55).  We chose ENSA as a specific 
focus for additional validation by chemical shift perturbation mapping experiments because 1) its 
relatively small size makes it especially amenable to study by solution NMR, and 2) it was 
previously reported to be downregulated in Alzheimer’s disease (33), Down’s Syndrome (34), 
and several models of learning and stress (56). 
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3.6.2 Structural analysis of AS-ENSA interaction. 
NMR chemical shift perturbation mapping experiments were carried out both to demonstrate 
site-specific effects and to provide a structural context for data interpretation.  AS in aqueous 
solution is unfolded, with only a small degree of secondary structure; in this state, only non-
specific interactions between AS and the partner proteins are observed, involving residues in the 
acidic C-terminus of AS with ENSA, which has a net positive charge at pH 7.5.  The amplitude 
of these effects is in most cases less than 0.003 ppm, with changes on the order of 0.01 ppm for 
only a few residues.  With ARPP-19, even the C-terminus of AS shows only extremely small 
changes.   
In contrast, the micelle-bound state of AS, which has a distinct helical hairpin fold as 
recently determined by Ulmer et al. (36), gives rise to a consistent and systematic pattern of 
chemical shift perturbations.  These chemical shift patterns observed for 15N-AS in the presence 
of ENSA are appreciated in the context of the 3D structure of AS (Fig. 9). The AS structure 
(PDB entry 1XQ8) as determined by Ulmer et al. (36) is illustrated with residues color-coded 
according to the magnitude of the chemical shift perturbation observed at the highest 
concentration of ENSA used here.  Blue residues have less than 0.015 ppm shifts, which is likely 
of no significance.  White and pink range from 0.015 ppm to ~0.035 ppm, significantly greater 
than the noise or uncertainty of peak positions. Darker red sites have greater than 0.035 ppm 
shifts, which are highly significant, an order of magnitude greater than the random measurement 
error.  The ribbon diagram (Fig. 9A) is labeled with specific amino acid locations, and the van 
der Waals radii depiction (Fig. 9B) emphasizes the strong correlation of perturbed sites with 3D 
structure.  
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Figure 3.9 Chemical shift perturbation mapping of SDS micelle-bound AS. 
Chemical shift perturbation mapping of SDS micelle-bound AS upon interaction with ENSA.  (A) Ribbon 
diagram of SDS micelle-bound AS structure (PDB entry 1XQ8, Ulmer et al.) in ribbon format, with key 
positions in the sequence labeled by amino acid residue.  Sites of  PD-associated mutations are indicated 
in bold. (B) The same structure and point of view in van der Waals representation. The chemical shift 
perturbation was defined as δ = ([0.1δN]2 + δH2)1/2). 
Using this structure, the pattern of chemical shift perturbations illustrates the regiospecific 
interaction. The C-terminal domain (far right unfolded region in Fig. 9A) of AS has no 
significant perturbations, but the N-terminal domain of SDS-bound AS has a number of 
prominent perturbations upon addition of ENSA.   Residues V3, A11, K12, A19, E20, T22 and 
V26 all change by more than 0.03 ppm, more than 0.06 ppm in the case of A19 and E20 (as 
summarized in Fig. 7B), and additional changes of significance (>0.015 ppm) are observed 
throughout the subsequent two turns of the helix, with residues Q24, G25, A27, E28, A29 and 
A30, the latter being one of the early-onset PD mutation sites. These residues in the N-terminal 
helix (helix A) are close in 3D space to a second set of residues in helix B, starting at 
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approximately K58 (across from E28) and extending to V74 (across from A11).  All resolved 
signals in this K58 to V74 stretch show changes of >0.02 ppm K60, V63, V66, A69, V71 and 
V74 change by more than 0.05 ppm, an order of magnitude greater than the threshold of 
significance.  (Signals for residues T59 and N65 are not sufficiently well resolved to determine 
the perturbation values.) Both micelle-facing residues (V52, Q62, V77, T81) as well as solvent-
exposed residues (E61, T72, A76), are perturbed significantly, indicating subtle but significant 
structural effects on both sides of the helix.  The locations of these interactions both on helices A 
and B, close in the folded structure but distant in the primary sequence, imply that ENSA is 
likely to have a specific interaction with this domain of the folded AS molecule on the micelle. 
A third region that is significantly perturbed includes the loop between helices, from V37 to 
G47, and the start of helix B.  Residues in the loop demonstrating significant chemical shift 
perturbations include T44, E46, H50, V52, A53 and T54; among these are two of the early-onset 
mutation sites in AS, as labeled on Fig. 9. The other mutation site, A30P, is near the region of 
significant perturbations in helix A. Reorientation of this helix or substantial differences in the 
dynamics, as observed in recent studies (36, 57), may alter binding affinity with ENSA. 
One trivial explanation for the observed perturbations is that they arise from competition for 
micelle surface area.  For example, some AS signals with perturbed chemical shift were facing 
the micelle.  This raised the question of whether AS and ENSA were competing for a common 
micelle, so that the chemical shift perturbations on the solvent-exposed surface of AS were an 
indirect consequence of this competition.  Several lines of evidence rule out this possibility.   
First, the chemical shift perturbations upon addition of ENSA to the SDS-bound AS sample 
are on average only a few percent of the chemical shift changes observed upon AS folding.  
Second, if ENSA were displacing AS from the micelle, the chemical shifts would move 
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systematically back in the direction of unfolded AS.  This also is not the case; rather, chemical 
shifts are perturbed in directions that are not correlated to the free state of AS, but a third state 
(i.e., the molecular complex consisting of AS-SDS and ENSA-SDS).  Third, a competition for 
the micelle would result primarily in changes of chemical shifts corresponding to those sites with 
the strongest interactions with the micelle, such as the Lys residues whose sidechains specifically 
coordinate with the phosphate headgroups, or the other aliphatic residues that have sidechains 
buried into the detergent.  Although some micelle-facing residues are perturbed upon addition of 
ENSA to the SDS-bound AS sample, these are by no means the only residues demonstrating 
shifts, and indeed many of the largest shifts are observed for sites that face the aqueous 
environment.  The observations in all three cases suggest a model of each protein (AS and 
ENSA) bound to its own micelle and interacting at the interface. 
We tested this hypothesis directly by performing an additional series of experiments in which 
SDS was titrated into a solution of 15N-AS and natural abundance ENSA in equimolar quantities 
(Fig. 8).  These spectra show that in the limit of excess protein (e.g., SDS ratios of 35:1:1, 70:1:1 
or 105:1:1, where there would be respectively 0.5, 1.0 or 1.5 micelles for every 2 protein 
molecules), high molecular weight complexes and/or species in intermediate chemical exchange 
are present.  Signals from the N-terminal domain of AS are broadened beyond detection (as 
observed by Eliezer with small unilamellar vesicles (15)).  As the number of micelles approaches 
and then exceeds the number of protein molecules, the signals from AS increase in intensity 
substantially.  Once a sufficient excess of SDS is achieved, no further changes occur. For 
example, in Fig. 8C, signals corresponding to the micelle-bound states of E46, A56, T64, G73, 
V74, T92 and G93 appear, and these signals increase in strength as the SDS-to-protein ratio is 
further increased to 140:1:1 (Fig. 8D) and 170:1:1 (Fig. 8E).  Only a few subtle changes are 
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observed between these two spectra, and addition of a further large excess of SDS (to a final 
ratio of 280:1:1, or 4.0 micelles per 2 protein molecules, Fig. 8F) causes no further changes.   
This experiment demonstrated that the order of addition of reagents did not influence the 
result and the result does not depend on the precise amount of SDS once in sufficient excess.  
Based on this result, we performed all the partner protein titration experiments with sufficient 
excess of SDS (at least 170 molecules of SDS per AS molecule). 
3.6.3 Functional significance of AS interactions with ENSA and ARPP-16/19. 
The precise cellular functions of the cAMP-regulated phosphoproteins ENSA and ARPP-19 
are still unclear.  Despite their high degree of primary sequence similarity, these two proteins 
have been characterized independently and in quite varying contexts.  ENSA was originally 
described as an endogenous ligand for the sulfonylurea receptor SUR1 (32), a subunit of the 
ATP-sensitive K+ channel. ARPP-16 and -19, along with ARPP-21 and DARPP-32, were 
originally described as robust phosphorylation substrates for PKA in brain (58). It is speculated 
that ARPP-16 may be involved in dopamine signaling, as it is enriched in basal ganglia, 
phosphorylated as a result of D1 dopamine receptor activation, and dephosphorylated in response 
to D2 activation (59).  Its precise cellular function has not been defined, however. Similar to 
ENSA, expression of ARPP-19 is downregulated in Down’s syndrome and Alzheimer’s disease; 
this is accompanied by a downregulation of PKA (60).  While our data do not immediately 
reveal a specific function for AS, or for the interaction between AS and ARPP family members, 
it is suggestive of participation by these proteins in a protein signaling network associated with G 
protein-coupled receptors. 
We have mapped the domain of AS interaction with ENSA to residues in the N-terminal 
helical domain of AS, a region that is structured only in the presence of membrane lipids or lipid 
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mimetics. We have determined the Kd of the AS-ENSA interaction to be ~61±12 µM in the 
presence of SDS micelles, based on analysis of the chemical shift changes as a function of ENSA 
concentration (61, 62). This value was determined by titrating SDS-bound ENSA into SDS-
bound AS.  No interaction is detectable between the proteins in aqueous solution.  
Relatively few proteins have been shown to interact specifically with the N-terminal domain 
of AS; our search of the research literature revealed only calmodulin (63), hDAT (64), synphilin 
(65), Aβ peptide (66), and PLD1 (67).  Interactions with Aβ and PLD1 were lipid-independent.  
Of the other 3 proteins, only calmodulin has been characterized with respect to affinity and lipid-
dependence.  Calmodulin binds AS with Kd ~ 1 µM, and binds either free or membrane-bound 
AS.  Interestingly, calmodulin binding causes AS to dissociate from the membrane.    
The affinity of the AS-ENSA  interaction (~61µM) is typical for regulatory interactions 
among proteins in signaling networks.  Like AS, ENSA and ARPP-19 are intrinsically 
unstructured proteins (IUP’s) ((68) (37).  One characteristic of such proteins is that they can 
achieve highly specific binding with partner proteins via low affinity interactions, which is 
advantageous in functional contexts requiring multiple interacting partners on a timescale of 
coordinated biological processes (69). Such specific yet reversible binding events are critical for 
the proper functioning of protein signaling networks, which has been proposed to account for the 
association of IUP’s with such networks. For example, several low-affinity binding interactions 
have been identified in the endocytic pathway (70); many of these interactions have Kd values on 
the order of 5 to 500 µM (69, 71). We envision a similar complexity of the interactions of AS 
with multiple partner proteins in accomplishing its biological functions. 
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3.7 Conclusion. 
We present an important proof-of-principle that the N-terminus of AS can function as a 
membrane-dependent scaffold for interactions with other proteins.  It is well established that 
membrane binding by AS is mediated by a series of imperfect 11-mer repeats at its N-terminus, 
spanning ~100 of a total of 140 residues (14, 36).  The domain encompassing residues 1-102 is 
92% identical among birds and mammals.  In the presence of phospholipid vesicles, these repeats 
fold into an amphipathic helix that lies parallel to the membrane surface.  In the absence of lipid, 
the repeat-containing domain has no stable structure (13). 
The molecular significance of the extended, structurally plastic helical domain has so far 
been a mystery.  A similar structural mechanism mediates lipid interactions by the exchangeable 
apolipoproteins, but these proteins are not as well conserved at the primary sequence level as AS 
(72, 73).  We show here that the helical N-terminus of AS is capable of mediating specific 
interactions with other proteins.  Because this helical structure is itself membrane-dependent and 
readily reversible, any protein complexes assembled around it should also be transient and 
sensitive to changes in the local membrane environment (e.g. via action of phospholipases or 
phospholipid kinases).  
We therefore propose that the unique, plastic structure of AS subserves its function as a lipid-
dependent protein scaffold.  One consequence of this structural plasticity is that AS may 
continually cycle through unfolded or partially folded states, which could explain its particular 
propensity to self-associate into oligomers or fibrils, as observed in Parkinson’s disease.  In this 
context, lipid-dependent protein interactions might stabilize the folded structure of AS, 
decreasing its in vivo oligomeric potential.  In such a scenario, PD-associated point mutations in 
the N-terminal domain (A30P, A53T, E46K) might promote misfolding of AS by disrupting 
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interactions with partner proteins.  Further analysis of this novel class of AS-interacting proteins 
is warranted to assess the potential for dynamic participation of AS in signaling complexes at the 
membrane surface. 
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CHAPTER 4 
1H, 13C and 15N Resonance Assignment of the cAMP-regulated 
Phosphoprotein Endosulfine-Alpha in Free and Micelle-Bound 
States 
4.1 Notes and Acknowledgements 
This chapter was adapted from John M. Boettcher, Kevin L. Hartman, Daniel T. Ladror, Zhi 
Qi, Wendy S. Woods, Julia M. George, and Chad M. Rienstra, Biomol. NMR Assign. 2007, 1, 
167-169. This work was supported by the University of Illinois (startup funds to C.M.R.) and the 
Research Corporation (Cottrell Scholars Award to C.M.R.). 
4.2 Abstract 
13C, 15N, and 1H chemical shift assignments are presented for the cAMP-regulated 
phosphoprotein endosulfine-alpha in its free and micelle-bound states. Secondary chemical shift 
analysis demonstrates formation of four helices in the membrane-bound state, which are not 
present in the absence of membranes. 
4.3 Biological context 
Endosulfine alpha (ENSA) was originally identified as an endogenous regulator of ATP-
sensitive potassium channels (K-ATP channels), which function as metabolic sensors in a variety 
of cell types, and are known to play a central role in the regulation of insulin secretion (1). K-
ATP channels are the molecular targets of sulfonylurea drugs, a class of compounds used widely 
in the treatment of type II diabetes (2). Sulfonylureas bind to the sulfonylurea receptor (SUR) 
subunits of K-ATP channels in the pancreatic β cell membrane. The resulting inhibition of K+ 
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currents causes membrane depolarization and activation of voltage-gated Ca2+ channels, 
triggering insulin release.  
Based on the identification of the SUR subunits as specific receptors for sulfonylurea drugs, 
the existence of endogenous ligands for these receptors was proposed, akin to the discovery of 
endorphins as endogenous ligands for opioid receptors (3). ENSA was thus purified from ovine 
brain in a biochemical screen for proteins that could compete with sulfonylurea drugs for binding 
to the K-ATP channel (4). Recombinant ENSA protein was shown to inhibit K+ currents in 
reconstituted pancreatic K-ATP channels, leading to the proposal that ENSA might regulate 
insulin secretion (5). The amino acid sequence of ENSA is highly similar to the cAMP-regulated 
phosphoproteins ARPP-16 and –19, which are all robust substrates for protein kinase A (PKA) 
phosphorylation (6). 
There is no published structural data available for ENSA and its interactions have, so far, 
only been observed at low resolution. Here we report the backbone and side-chain resonance 
assignments of ENSA bound to sodium dodecyl sulfate (SDS) micelles and free in aqueous 
buffer. Second shift analysis demonstrate that ENSA undergoes a conformational change in the 
presence of lipid mimetics, forming four well-ordered helices.  
4.4 Methods and experiments 
4.4.1 Recombinant protein expression  
For isotopically labeled ENSA, cultures were grown in M9 minimal media supplemented 
with 2 g [13C]-glucose, 1 g [15N]-ammonium chloride, 10 mg biotin, 10 mg thiamine and 10 ml 
[13C, 15N]-Bioexpress (Cambridge Isotopes Laboratories, Inc., Andover, MA). The ENSA 
construct was prepared in pET21 vector (Novagen).  Protein expression was induced with IPTG 
at 30 ºC, followed by alkaline lysis, boiling, and precipitation with 60% ammonium sulfate. 
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Precipitates were resolubilized and purified by hydrophobic interaction chromatography on a 
HiPrep 16/10 Butyl Fast Flow Sepharose column (GE Biosciences), and eluted with decreasing 
salt. ENSA-containing fractions were pooled and concentrated, then subjected to high-resolution 
gel filtration chromatography (HiPrep 16/160 Sephacryl S-200, GE Biosciences). 
4.4.2 NMR Spectroscopy 
Solution NMR spectra were acquired at the VOICE NMR Facility (School of Chemical 
Sciences, University of Illinois at Urbana-Champaign) on a Varian INOVA 600 MHz 
spectrometer equipped with a 5 mm, triple resonance (1H-13C-15N) triaxial gradient probe, 
using VNMRJ version 2.1B with the BioPack suite of pulse programs released in early 2006.  2D 
1H-15N HSQC spectra were measured for an average of two hours per spectrum, digitizing 512 
points in the indirect 15N dimension (t1max = 232 ms). The standard suite of heteronuclear triple 
resonance 3D spectra (HNCO, HNCA, HNN, HNCACB, CBCA(CO)NH) was utilized to 
establish correlations among backbone resonances. Measurement times for the 3D spectra were 
12 to 48 hours. Side chain 1H resonances were assigned using HC(CO)NH, HCCH-TOCSY and 
NOESY-HSQC spectra.  
Spectra were processed with NMRPipe (7) and analyzed in Sparky (8). The free state 
consisted of 0.5 mM 15N, 13C-labeled-ENSA in 50 mM phosphate buffer, pH 7.4, 10% D2O. All 
subsequent SDS solutions were prepared using the same buffer (pH ~7.4) to minimize chemical 
shift perturbations due to changes in pH or ionic composition during titrations. The SDS micelle-
bound state of ENSA was prepared by addition of 750 mM sodium dodecyl sulfate (SDS), with a 
final concentration of at least 70 mM, i.e., a 140:1 molar ratio of SDS to ENSA, beyond which 
no further changes in chemical shifts were observed. In all NMR experiments, the 15N or 15N, 13C 
ENSA sample was filtered (0.2 mm) and first examined in the unfolded state by HSQC 
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experiments; immediately thereafter, SDS was added to prepare the bound state. Sample lifetime 
under these conditions typically ranged from five to seven days. HSQC spectra were acquired in 
between blocks of lengthier 3D experiments to confirm sample integrity. In SDS micelle-bound 
samples the concentration of SDS significantly exceeded its critical micelle concentration. 
 
4.5 Extent of assignments and data deposition 
 
Figure 4.1 15N-1H 2D HSQC NMR spectra of ENSA. 
(a) ENSA free in aqueous buffer solution at 10 ºC; (b) bound to SDS micelles at 25 ºC.  All the spectra 
were acquired with 4 scans per row, 512 rows, processed with sine bell apodization and zero filled in each 
dimension. 
The 1H -15N HSQC spectrum for ENSA free in solution is shown in Figure 1. HN, N, Cα, 
C’ and Cβ backbone assignments were performed (to ~91% completeness) with standard triple 
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resonance methods. No assignments were made or the first 3 residues (M1, S2, Q3) and the K4 
assignments are tentative. The assignments were deposited in the BMRB under accession 
number 15136 (for release upon publication). The spectra demonstrate all the anticipated features 
of a predominantly unfolded protein, including minimal dispersion of 1H chemical shifts, rapid 
and strongly temperature-dependent exchange of most amide proton sites with water, and small 
secondary chemical shifts (9). At 10 °C, the 1H -15N HSQC spectrum (Figure 7.1a) contains 110 
of the 112 expected peaks in the amide region (excluding 9 Pro residues). The dispersion of the 
amide peaks in the 1H dimension is only ~0.8 ppm, typical of proteins with minimal secondary 
structure. Moreover, compared to the spectrum acquired at 10 °C, the HSQC spectrum at 25 °C 
(data not shown) shows substantial decreases in signal intensities throughout the spectrum and 
prominent upfield shifts of most peaks, indicating rapid chemical exchange with water. 
Consensus chemical shift index (CSI) (10) analysis demonstrates that one short helix is present 
from residues 32 to 36, while other short stretches (e.g. 71 to 75) possess slight helical 
tendencies (i.e., although strictly random coil the population of helical conformations is likely 
higher than beta-sheet, based on the fractional secondary shifts). In addition, some residues show 
beta-sheet tendencies; these regions include a stretch of several near the N terminus (N9, A11, 
T14, E16), and several near or at the C terminus (I97, T99, V110, T111, S112, K113 and E121). 
These trends are modest and not indicative of well-ordered secondary structure, but residual 
secondary structure in a mostly unfolded protein. All other sites in ENSA (80% of the sequence) 
have unambiguous characteristics indicative of an unfolded protein.  
 The SDS micelle-bound state yielded essentially all of the expected cross peaks in this 
case despite the lack of 2H labeling. Figure 1b shows the 1H -15N HSQC spectrum of ENSA 
bound to SDS micelles at 25 °C. The quality of the data enabled nearly ~98% of HN, N, Cα, Cβ, 
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and C’ resonance assignments. The majority of the proton and carbon side chain chemical shift 
assignments were performed using a combination of 3D spectra. Residues preceding proline 
residues (9 total) are missing C’ assignments and no assignments were possible for the first 
residue (M1).  The assignments were deposited in the BMRB under accession number 15135 (for 
release upon publication). CSI analysis (10) indicated an increase in the degree of helical 
structure throughout the protein. Semi-empirical analysis of the chemical shifts was also 
performed using the program TALOS (11). TALOS-reported φ and ψ backbone dihedral angles 
confirm the helical structures reported by CSI analysis. The first helix identified by chemical 
shift analysis extends from residue 34 to 39, whereas in the free state only a few residues in this 
region could confidently be identified as helical. The three new helices consist of residues 49 to 
64, 68 to 78 and 106 to 113. The fourth helix, which includes the PKA phosphorylation site S109 
(5), shows no secondary structure in the free state. Several residues retained beta sheet 
tendencies, as seen in the ENSA free in solution. This included stretches near the N terminus and 
several near the C terminus. 
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CHAPTER 5 
Membrane-Induced Folding of the cAMP-Regulated 
Phosphoprotein Endosulfine-Alpha 
5.1 Notes and Acknowledgements 
This chapter was adapted from John M. Boettcher, Kevin L. Hartman, Daniel T. Ladror, Zhi 
Qi, Wendy S, Woods, Julia M. George, and Chad M. Rienstra, Biochemistry. 2008, 47, 12357-
12364. This work was supported by grants from the Research Corporation (Cottrell Scholars 
Award to CMR), the University of Illinois and the Branfman Family Foundation (to JMG) 
5.2 Abstract  
Endosulfine alpha (ENSA) is a 121-residue cAMP-regulated phosphoprotein, originally 
identified as an endogenous regulator of ATP-sensitive potassium channels. ENSA has been 
implicated in the regulation of insulin secretion, and expression of ENSA is decreased in brains 
of both Alzheimer’s disease (AD) and Down’s syndrome patients. We recently described 
membrane-dependent interactions between ENSA and the Parkinson’s disease associated protein 
alpha-synuclein.  Here we characterize the conformational change in ENSA that occurs upon 
binding to membranes. Secondary chemical shift analysis demonstrates formation of four helices 
in the lipid-bound state that are not present in the absence of lipid. The helical structure is 
maintained in several different lipid mimetics (sodium dodecyl sulfate, dodecyl phosphocholine, 
lyso 1-palmitoyl phosphatidylglycerol, and phospholipid vesicles).  Introduction of a mutation 
(S109E) to mimic PKA phosphorylation of ENSA leads to a perturbation of the fourth helix and 
disrupts the interaction with alpha-synuclein.  These data establish ENSA as an intrinsically 
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unstructured protein that adopts a stable structure upon membrane binding, properties it shares 
with its binding partner alpha-synuclein. 
5.3 Introduction 
Endosulfine alpha (ENSA) is a small cytosolic protein belonging to the cAMP-regulated 
phosphoprotein (ARPP) family (1).  It was originally identified as an endogenous regulator of 
ATP-sensitive potassium channels (K-ATP channels), which function as metabolic sensors in a 
variety of cell types, where they couple secretory activity to the availability of ATP (2). K-ATP 
channels are the molecular targets of sulfonylurea drugs, a class of compounds used widely in 
the treatment of type II diabetes (3). Sulfonylureas bind to the sulfonylurea receptor (SUR) 
regulatory subunits of K-ATP channels in the pancreatic β cell membrane, leading to closure of 
the channel pore. The resulting inhibition of K+ currents causes membrane depolarization and 
activation of voltage-gated Ca2+ channels, triggering insulin release. These same channels 
mediate glucose-stimulated insulin secretion, as they are alternately inhibited and activated via 
binding of metabolically produced ATP or MgADP to the SUR subunits. In brain tissue, K-ATP 
channel closure is associated with neurotransmitter release (4).  
Based on the identification of the SUR subunits as specific receptors for sulfonylurea drugs, 
the existence of endogenous ligands for these receptors was proposed, akin to the discovery of 
endorphins as endogenous ligands for opioid receptors (5). ENSA was thus purified from ovine 
brain in a biochemical screen for proteins that could compete with sulfonylurea drugs for binding 
to the K-ATP channel (6). Recombinant ENSA protein was shown to inhibit K+ currents in 
reconstituted pancreatic K-ATP channels, leading to the proposal that ENSA might regulate 
insulin secretion (7). Recent studies have failed to observe localization of ENSA to rat pancreatic 
β cells, raising some doubts regarding its proposed role in insulin secretion (8). However, other 
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reports have demonstrated regulation of ENSA expression by glucose in mesangial cells of the 
kidney (9), which also express K-ATP channels that are sensitive to sulfonylureas.  Treatment of 
insulin-deficient rats with low doses of glibenclamide (to mimic the effects of increased ENSA 
expression) protected against the development of glomerulosclerosis, a typical complication of 
diabetes (10). 
While the function of ENSA has not been analyzed in the brain, its expression varies 
significantly in several pathological and functional contexts. ENSA protein is greatly decreased 
in frontal cortex and cerebellum of Alzheimer’s patients (11) and in Down’s syndrome patients 
with Alzheimer’s disease pathology (12).  ENSA mRNA is down-regulated in rat hippocampus 
with long-term memory consolidation, but up-regulated with swimming-related stress (13). 
Recent studies suggest that modulation of K-ATP channel activity by oxidative stress contributes 
to the differential vulnerability of midbrain dopamine neurons to neurodegeneration in 
Parkinson’s disease (14), but a potential role for ENSA in this process has not been considered. 
We recently identified ENSA in a screen for conformation-dependent binding partners of 
alpha-synuclein (AS), an activity-dependent inhibitor of synaptic neurotransmission (15, 16) 
which is associated with both familial (17-21) and sporadic (22, 23) Parkinson’s disease.  The 
two proteins were found to interact only in the presence of SDS micelles or small unilamellar 
vesicles (24), conditions known to promote a dramatic conformational shift in AS from random 
coil to alpha helix (25).  We speculate that ENSA and AS interact physiologically in a 
membrane-dependent fashion to regulate neuronal excitability and synaptic vesicle release.  Here 
we use a combination of solution NMR, circular dichroism spectroscopy, and gel exclusion 
chromatography to characterize the structure of lipid-bound ENSA, and to investigate the 
potential effects of PKA phosphorylation on the lipid-dependent interactions of ENSA and AS. 
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5.4 Experimental Procedures 
5.4.1 Recombinant protein expression.  
For isotopically labeled protein, cultures were grown in M9 minimal media supplemented 
with 2 g [13C]-glucose, 1 g [15N]-ammonium chloride, 10 mg biotin, 10 mg thiamine and 10 ml 
[13C, 15N]-Bioexpress (Cambridge Isotopes Laboratories, Inc., Andover, MA). The wild type and 
S109E ENSA constructs were prepared in pET21 vector (Novagen).  Protein expression was 
induced with IPTG at 30 ºC, followed by alkaline lysis, boiling, and precipitation with 60% 
ammonium sulfate. Precipitates were resolubilized and purified by hydrophobic interaction 
chromatography on a HiPrep 16/10 Butyl Fast Flow Sepharose column (GE Biosciences), and 
eluted with decreasing salt. ENSA-containing fractions were pooled and concentrated, then 
subjected to high-resolution gel filtration chromatography (HiPrep 16/160 Sephacryl S-200, GE 
Biosciences). 
Full-length, untagged AS protein was produced for NMR experiments according to published 
procedures (26). Protein concentrations were determined spectrophotometrically by measuring 
absorbance at 280 nm assuming molar extinction coefficients of 4470 M-1cm-1 and 5200 M-1cm-1 
for ENSA and AS respectively.  
5.4.2 Circular Dichroism Spectroscopy   
Circular dichroism spectra were acquired on a Jasco J720 Spectropolarimeter at room 
temperature. Spectra were taken on ENSA free in solution and in the presence of lyso 1-
palmitoyl phosphatidylglycerol (LPPG), dodecyl phosphocholine (DPC), sodium dodecyl sulfate 
(SDS) and small unilamelar vesicles (SUV). In all samples ENSA was at a concentration of 15 
µM. The concentration of LPPG, DPC and SDS was 20 mM. The concentration of the small 
unilamellar vesicles was 4 mg/ml.    
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5.4.3 NMR Spectroscopy 
Solution NMR spectra were acquired at the NMR Facility (School of Chemical Sciences, 
University of Illinois at Urbana-Champaign) on a Varian INOVA 600 MHz spectrometer 
equipped with a 5 mm, triple resonance (1H-13C-15N) triaxial gradient probe, using VNMRJ 
version 2.1B with the BioPack suite of pulse programs released in early 2006.  2D 1H-15N HSQC 
spectra were measured for an average of two hours per spectrum, digitizing 512 points in the 
indirect 15N dimension (t1max = 232 ms). The standard suite of heteronuclear triple resonance 
3D spectra (HNCO, HNCA, HNCACB, CBCA(CO)NH) was utilized to establish correlations 
among backbone resonances for the S109E sample. Measurement times for the 3D spectra were 
12 to 48 hours. In all spectra, the direct 1H dimension was acquired over a ~15 ppm bandwidth 
with an acquisition time (t3max) of at least 100 ms, using standard 15N and 13C decoupling 
methods. The HNCO spectrum was digitized with 64 points in the 13C dimension and 48 points 
in the 15N dimension (t1max = 21 ms, t2max = 22 ms). The HNCA spectrum was digitized with 
64 points in the 15N dimension and 48 points in the 15N dimension (t1max = 14 ms, t2max = 22 
ms). The HNCACB spectrum was digitized with 96 points in the 13C dimension and 60 points in 
the 15N dimension (t1max = 8 ms, t2max = 25 ms). The CBCA(CO)NH spectrum was digitized 
with 64 points in the 13C dimension and 48 points in the 15N dimension (t1max = 5 ms, t2max = 22 
ms). Spectral widths were adjusted to cover the bandwidths of interest, using default parameters 
in the BioPack software. Steady-state heteronuclear {1H}-15N NOE experiments were acquired 
on 15N-labeled ENSA. {1H}-15N NOE spectra were acquired for ENSA in the free (10 °C) and 
SDS micelle-bound (>140:1 SDS to ENSA ratio, 25 °C) states. This included one spectrum with 
proton saturation and one without saturation during a 5 s relaxation delay. The acquisition time 
for each spectrum was ~12 hours.   
  87 
Spectra were processed with NMRPipe (27) and analyzed in Sparky (28). The free state 
consisted of 0.5 mM 15N, 13C-labeled-ENSA in 50 mM phosphate buffer, pH 7.4, 10% D2O. All 
subsequent lipid mimetic solutions were prepared using the same buffer (pH ~7.4) to minimize 
chemical shifts due to changes in pH or ionic composition during titrations. The titrations were 
performed by the addition of the lipid mimetic solution directly to the NMR tube. The SDS 
micelle-bound state of ENSA was prepared by addition of 750 mM SDS in 4.6 ml aliquots, 
achieving a final concentration of at least 70 mM, i.e., a 140:1 molar ratio of SDS to ENSA. The 
LPPG micelle-bound state of ENSA was prepared by the addition of 120 mM LPPG solution in 
40 µl aliquots, achieving a final concentration of at least 60 mM, a 120:1 molar ratio of LPPG to 
ENSA. DPC micelle-bound state of ENSA was prepared by the addition of 150 mM DPC 
solution in 29.5 µl aliquots, achieving a final concentration of at least 60 mM, a 120:1 molar 
ratio of DPC to ENSA. The SUV-bound ENSA sample started with a 0.15 mM ENSA sample, 
and a 54 mM SUV solution was added in 58.3 µL aliquots. The final concentration reached was 
22 mM SUV concentration (250:1 SUV:ENSA molar ratio). The S109E mutant was prepared in 
the SDS micelle-bound state in the same manner as the wild type ENSA and following similar 
stoichiometry. For all NMR experiments, ENSA (wild type and S109E) was filtered (0.2 µm) 
and first examined in the unfolded state by HSQC experiments; immediately thereafter, lipid 
mimetic was added to prepare the bound state and additional HSQC experiments acquired to 
confirm the titration end point. During subsequent experiments and for spectra of the WT and 
S109E ENSA-AS interaction, natural abundance AS was titrated immediately thereafter to the 
SDS micelle-bound ENSA and followed the procedure previously described (24). Sample 
lifetime under these conditions typically ranged from five to seven days. HSQC spectra were 
acquired in between blocks of lengthier 3D experiments to confirm sample integrity. In all the 
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lipid-bound samples the concentration of lipid mimetic significantly exceeded its critical micelle 
concentration. 
5.4.4 Vesicle Preparation 
1-Palmitoyl 2-oleoyl phosphatidylcholine (POPC) and 1-palmitoyl 2-oleoyl phosphatidic 
acid (POPA) in chloroform were purchased from Avanti Polar Lipids (Alabaster, AL). A thin 
film of 3:1 POPC and POPA mixture was evenly applied to the inside of a round bottom flask 
under gentle N2 stream and then allowed to fully evaporate over at least half an hour. The dry 
lipids were resuspended in 3.5 ml low salt STB buffer (7.7 mM Tris, 50 mM  NaCl, 10 mM  
EDTA, pH 7.4) per 60 mg lipids, followed by a 2-hour sonication in a Branson 2510 bath 
sonicator (Branson Ultrasonics, Danbury, CT) (29). The solution was ultracentrifuged at 55,000 
rpm (~125,000 x g) in a TLA 100.3 rotor for 2 h at 25 °C according to a previous protocol (25). 
The top two-thirds of the solution at this stage contained a significant amount of multilamellar 
vesicles (MLVs), as confirmed by HPLC (30). Preparative-scale HPLC was impractical for 
preparation of quantities of SUVs required for NMR studies.  Rather, centrifugation at 85,000 
rpm (~300,000 g) for 2.5 hours separated SUVs from MLVs. To improve the yield of SUVs, the 
bottom one-third fraction was collected from several centrifuge tubes and sonicated for two 
hours (30).  
5.5 Results 
5.5.1 ENSA is an unfolded protein in solution and forms a helical structure in complex with lipid 
mimetics  
Solution NMR was previously used to characterize the structure of ENSA in aqueous buffer 
and in the presence of sodium dodecyl sulfate (SDS) micelles (31).  In the absence of SDS, the 
spectra demonstrated all the anticipated features of an unfolded protein, including minimal 
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dispersion of 1H chemical shifts (Figure 1A), rapid and strongly temperature-dependent 
exchange of most amide proton sites with water (Figure 1B) and small secondary chemical shifts 
(32). Consensus chemical shift index (CSI) (33) analysis concurred that ENSA is a 
predominantly unfolded protein in aqueous buffer, possessing secondary structure only in one 
short helix (residues 32 to 36). Heteronuclear 1H-15N NOE experiments revealed low order 
parameters throughout, consistent with this disordered state (data not shown).  Closer 
examination of the secondary chemical shifts (Figure 2A) illustrates a small residual helicity 
among two other short stretches of residues. 
 
Figure 5.1 15N-1H 2D HSQC NMR spectra of ENSA. 
(A) Free (lacking detergent micelles) in solution at 10 ºC (modified with permission from Figure 1 of Ref. 
(31)); (B) free in solution at 25 ºC.  All the spectra were acquired with 4 scans per row, 512 rows, 
processed with sine bell apodization and zero filled in each dimension.  Additional experimental details 
are reported in the text. 
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In the presence of SDS, ENSA undergoes a prominent conformational change to a more 
helical structure (31). CSI and TALOS analysis (33, 34) indicated the formation of 4 helices, 
consisting of residues 34 to 39, 49 to 64, 68 to 78 and 106 to 114 (31).  Secondary Cα chemical 
shifts (Figure 2B) further confirm the significance of the change. Heteronuclear 1H-15N NOE 
experiments in this case revealed strong steady-state enhancements for the region from residue 
34 to 116; the terminal domains yielded weak negative NOE intensities, consistent with a lack of 
secondary structure. Within the ordered domain, highest NOE enhancements were observed for 
residue within the four helices (data not shown).  
 
Figure 5.2 Secondary chemical shifts of α-carbons in ENSA.  
Data are calculated as the deviation of the amino acid type-specific random coil value.  Positive values 
indicate helical structure. (A) ENSA in aqueous buffer. (B) ENSA bound to SDS micelles. 
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5.5.2 Gel filtration chromatography confirms ENSA binding to phospholipid membranes 
The observation that ENSA undergoes a conformational change in the presence of SDS 
micelles suggested that ENSA might also interact with phospholipid bilayers, a more 
physiologically relevant membrane environment.  We incubated ENSA (0.1 mg/ml) with small 
unilamellar phospholipid vesicles (SUV, 2 mg/ml) prepared at a ratio of 3:1 POPC/POPA, and 
separated the mixture by gel filtration chromatography (Figure 3). Chromatograms of pure 
ENSA and pure SUV were acquired as controls. Pure ENSA eluted at ~19 ml. The pure SUV  
 
Figure 5.3 ENSA binds phospholipid vesicles. 
Vesicles (2 mg/ml) prepared from a 3:1 mixture of POPC and POPA were incubated 10 minutes with 
recombinant ENSA protein (0.1 mg/ml), and the mixture was separated by gel filtration chromatography 
(…).  For comparison, lipid-free ENSA protein (—) and pure vesicles (---) were subjected to similar 
separation.  Pooled fractions (indicated by brackets) from the free ENSA and ENSA/lipid samples were 
separated by SDS-PAGE, stained with Coomassie blue, and visualized by scanning with the Odyssey 
infrared imaging system (inset). (Figure supplied by Wendy Woods and Dr. Julia George.) 
solution eluted predominantly at 14.5 ml, with two smaller peaks (representing larger 
multilamellar vesicles) detected near 10 ml (25). Upon incubation with SUV, the free ENSA 
peak essentially disappeared, and the SUV peak increased in intensity, indicating binding of the 
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protein to the phospholipid vesicles.  Integration of peak areas in the presence and absence of 
vesicles indicated that >80% of the protein bound under these conditions.   The SUV peak also 
eluted at a slightly lower elution volume, indicating an increase in the hydrodynamic radius of 
the vesicles upon protein binding. The MLV peaks were also shifted slightly, suggesting that 
ENSA binds these larger vesicles as well. The inset to Figure 3 shows SDS-PAGE gel 
electrophoresis of pooled fractions representing the free protein peak (lane 2) and the 
SUV:ENSA peak (lane 1) to confirm the shift in ENSA elution time in the presence of SUV. 
These data confirm that ENSA binds phospholipid vesicles. 
5.5.3 Far UV circular dichroism demonstrates conformational changes in the presence of lipid 
mimetic 
 
Figure 5.4 UV circular dichroism of ENSA. 
Far UV circular dichroism spectra plotted with mean residue ellipticity [Θ] as a function of wavelength 
for (A) ENSA: free in solution (black), with excess SDS (light blue), with excess DPC (red), with excess 
LPPG (purple). (B) CD spectra of ENSA free in solution (black) and with excess SUV (red). (Figure 
supplied by Dr. Julia George.) 
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 We next investigated the ENSA structure in complex with different membrane mimetics 
using far-UV circular dichroism (CD) spectroscopy, comparing the results to the SDS-induced 
structure. CD spectra were obtained for ENSA in the presence of micelles (SDS, dodecyl 
phosphocholine (DPC), or lyso 1-palmitoyl phosphatidylglycerol (LPPG)) and small unilamellar 
vesicles (SUV, 3:1 POPC/POPA). The CD spectra (Figure 4) agreed with the NMR analysis of 
SDS-bound ENSA, indicating little secondary structure for ENSA in the absence of lipid but 
significant increases in helical content in the presence of lipid mimetic; these structural elements 
are indicated by local minima at 208 and 222 nm (Figure 4). The CD spectra of ENSA in the 
presence of SDS and LPPG were very similar, indicating almost identical helical content for 
both, according to the intensity at 222 nm (35). The spectra obtained in the presence of DPC and 
SUV (Figure 4A,B) showed an increase in helical content over free ENSA, but less than in the 
presence of SDS or LPPG.  
5.5.4 HSQC spectra demonstrate structural changes of ENSA in the presence of several lipid 
mimetics 
The specific conformational events driving the association with membranes were examined 
further by solution NMR spectroscopy of 15N-ENSA in complex with the lipid mimetics (SDS, 
LPPG, DPC, and SUV) used previously for the CD experiments (Figure 5). In all cases, 
significant changes in the HSQC spectra are observed as the lipid mimetic-to-protein ratio is 
increased.  In the limit of excess lipid or detergent (molar ratio greater than 100:1 SDS:ENSA, 
LPPG:ENSA, and DPC:ENSA and greater than 200:1 SUV:ENSA) no further changes of 
statistical significance occur, indicating that ENSA exists in the lipid-bound state if provided a 
sufficient excess of lipid mimetic. The HSQC spectra obtained in the presence of SDS, LPPG 
and DPC at 25 °C (Figure 5A, B, C) demonstrate greater chemical shift dispersion than free 
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ENSA (~1.4 ppm for SDS and LPPG, ~1.1 ppm for DPC), consistent with an increase in 
secondary structure throughout the protein. Temperature-dependent chemical shift changes were 
also greatly reduced in the micelle-bound states, indicative of decreases in the accessibility of the 
protein to bulk water, as expected when the protein folds. 
Initial assignments were made of the spectra by observing changes from the free state 
assignments and during the course of the titrations with lipid mimetics. In the presence of SUV, 
many of the ENSA resonances broaden and become depressed in intensity, leaving only ~35 of 
the expected 112 resonances (Figure 5D) in the HSQC spectrum in the presence of SUVs. This is 
approximately half the number seen for ENSA in solution at 25 °C. The resonances remaining 
were assigned to the N and C termini, which are unstructured in the SDS micelle-bound samples 
(31). Likewise, in the presence of DPC and LPPG, the same ~45 peaks appear in similar regions 
of the spectrum, and have chemical shifts consistent with random coil conformations.  In 
addition to those signals that could be assigned straightforwardly, other resonances appeared at 
higher ratios of lipid to protein and therefore required de novo backbone assignment, which we 
performed for the SDS and LPPG bound states. The DPC spectra contained ~75 total peaks 
(excluding resonances associated with side chain amines) while both the SDS and LPPG spectra 
contained ~ 110 resonances.   
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Figure 5.5 15N-1H HSQC NMR spectrum of  ENSA bound to membrane mimetics. 
15N-1H HSQC NMR spectrum of (A) SDS micelle-bound ENSA (modified with permission from Figure 1 
of Ref. (31)); (B) LPPG micelle-bound ENSA, (C) DPC micelle-bound ENSA and (D) ENSA bound to 
SUV.  HSQC spectra were acquired as a function of lipid mimetic concentration to confirm the end point 
of the titration. An excess of lipid mimetic was employed for all subsequent experiments. Experimental 
and processing parameters are identical to those in Figure 1. 
  96 
5.5.5 Assignment and structural interpretation of the LPPG micelle-bound ENSA NMR data 
We have previously reported the assignments of the SDS micelle-bound sample (31).  To 
validate the significance of this conformation to the physiology of ENSA, we have further 
investigated this behavior with lysophospholipids and vesicles. The LPPG micelle is a better 
approximation of physiological lipids than is SDS, and so it was of interest to assess whether 
ENSA assumes the same detailed structural properties in this context.  Although the signals for 
the LPPG:ENSA complex were generally weaker and broader than the SDS micelle-bound 
ENSA (due to the larger size (~30 kDa) of the LPPG micelle) assignments were 80% complete.  
Resonances assigned to residues 6 to 30, 82 to 97 and 116 to 121 displayed high sensitivity and 
narrow line widths, which along with a lack of significant secondary shifts indicated that these 
regions of the protein are not directly bound to the micelle. Several other stretches of amino 
acids were assigned, despite depressed signal intensities, to regions within the same portions of 
the sequence that formed helices in the presence of SDS, and CSI analysis (33) for the assigned 
regions showed good agreement with the secondary structure domains observed in SDS. The 
helices found in the SDS micelle-bound sample are present in the LPPG micelle-bound sample, 
including the formation of a helix that contains S109, the site of phosphorylation by protein 
kinase A (PKA) (7).   
Figure 5 also illustrates that signals assigned in ENSA bound to SUV are consistent with 
random coil conformation.  Resonances from residues bound to the SUV (and in helical 
conformation, based upon the CD results) are broadened beyond detection; therefore assignments 
were possible only for regions where ENSA is not tightly bound to the vesicle.  These regions of 
the protein agree well with the disordered ENSA residues in the SDS, DPC and LPPG 
complexes.   
  97 
5.5.6 S109 phosphorylation affects the interaction of ENSA with membranes 
 
Figure 5.6 15N-1H 2D HSQC NMR spectra of S109E-ENSA. 
(A) 15N-1H 2D HSQC NMR spectra of S109E-ENSA Free (lacking detergent micelles) in solution at 10 
ºC; (B) SDS micelle-bound S109E-ENSA at 25 ºC. Experimental and processing parameters are identical 
to those in Figure 1. 
The results of the previous experiments indicate that ENSA undergoes a conformational 
change upon binding to membranes that includes the formation of the four helices reported 
previously for SDS (31). An interesting feature of the membrane-bound structure of ENSA is the 
formation of a helix that contains the site of phosphorylation (S109) by PKA (7). To examine the 
effect of phosphorylation on the structure of membrane-bound ENSA, we investigated a 
phosphorylation mutant, S109E, by NMR. Initially, HSQC spectra for S109E were obtained in 
the absence of membrane mimetic at 10 °C (pH 7.5, Figure 6A). The spectra were highly similar 
to wild type ENSA in solution and showed the same unstructured characteristics previously 
reported for wild type ENSA (31). Assignments for the S109E resonances in aqueous buffer 
therefore were presumed to be similar to the wild type ENSA assignments and confirmed 
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through a subset of 3D experiments. Regions showing significant chemical shift perturbations in 
the S109E mutant included not only the region near the mutation site, but also residues 30 to 40; 
this region contains the only element of secondary structure observed for ENSA in solution (31), 
a helix from residue 32 to 36.  
 
Figure 5.7 Chemical shift differences between wild type ENSA and the S109E mutant.  
N and HN differences were calculated for the 107 assigned residues in the HSQC spectra using the 
formula δ = ([0.1δN]2 + δH2)1/2, where δN and δH are the respective changes in 15N and 1H chemical shifts 
in the units of ppm.  
 
Next, NMR spectra were acquired on the S109E phosphorylation mutant of ENSA in the 
presence of saturating quantities of SDS (as confirmed by titrations as described above). HSQC 
(Figure 6B), HNCACB, HN(CO)CACB and HNCO spectra were acquired for the S109E 
micelle-bound sample and unambiguous assignments of CA, CB, CO, N and HN were obtained, 
from which the secondary structure could be inferred (33). The secondary structures are highly 
similar throughout the majority of the protein; however, the helix near the S109E mutation site is 
disrupted, containing only one helix turn (from residue 105 to 109) rather than three turns as 
observed in the wild type protein.  Chemical shift perturbation analysis (Figure 7) confirms that 
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the only significant change in local conformation must occur near the C-terminus, although some 
of these conformational events may be allosterically transmitted to the short N-terminal helix.  
Most of these latter changes are on the order of 0.01 to 0.03 ppm, at the limit of significance for 
this experiment. 
Previously, we used chemical shift perturbation mapping to explore the conformation 
dependence and structural specificity of the interaction of the neuronal protein α-synuclein (AS) 
and ENSA in the presence of SDS (24). Here we employ the same approach but with 15N-labeled 
ENSA and natural abundance AS. The ENSA-AS interaction depends upon the helical 
conformation of each protein; therefore we examined the effect of titrating SDS-bound AS into a 
preformed solution of SDS-bound ENSA. The chemical shift perturbations in ENSA were 
continuous and approximately linear in AS concentration (Figure 8A).  At a 1:1 molar ratio 
ENSA:AS, several ENSA residues show substantial changes in chemical shift (>0.03 ppm), 
including K4, Q5, several residues among L28 to E34, K89, G94, H96 and I97. Other residues 
showed smaller changes (0.01 to 0.03 ppm), while a majority of residues indicated no 
conformational change with differences in chemical shift within the expected error of the 
experiments (<0.01 ppm). We also performed chemical shift perturbation mapping with the 
ENSA S109E mutant (Figure 8B).  In contrast to the wild type behavior, only four peaks are 
perturbed (L28, K63, Y64 and L103), at the borderline of statistical significance, indicative of a 
much weaker interaction between AS and the S109E ENSA mutant, as compared to wild type.  
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Figure 5.8 Chemical shift perturbations upon titration of ENSA with AS. 
(A) Chemical shift changes upon interaction of micelle-bound wild type ENSA with AS. Chemical shift 
differences are reported as a function of residue number, where δ = ([0.1δN]2 + δH2)1/2 and  δN and δH are 
the respective changes in 15N and 1H chemical shifts in the units of ppm. (B) Chemical shift changes upon 
interaction of micelle-bound S109E-ENSA with AS.  Superimposed is a cartoon representation of the CSI 
predicted secondary structure for wild type membrane bound ENSA, with lines indicating random coil 
regions.  
5.6 Discussion 
5.6.1 ENSA forms a helical structure when bound to lipids   
ENSA is a predominantly unfolded protein in aqueous solution with some nascent structure 
present. We find that ENSA undergoes a major structural rearrangement when bound to lipids 
such that the protein has well-defined secondary structure. We previously observed that residues 
~30 to ~115 of ENSA, in the presence of SDS, adopt a helical structure (31). In the current 
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study, we demonstrate further that the binding is not SDS specific but that several lipid mimetics 
(DPC, LPPG and POPC/POPA SUVs) cause a similar conformational change. In all cases, 
increased helicity is observed in CD spectra (based upon ellipticity at 222 nm), which is 
confirmed by 1H-15N HSQC NMR spectra for the micelles.  Furthermore, the 1H-15N HSQC 
spectra of ENSA in the presence of SUVs show strong signals for only the disordered termini 
and loops; residues bound tightly to the vesicle tumble too slowly for conventional solution 
NMR spectra to yield narrow resonance lines (residues 30 to 116). Thus the observed resonances 
in the spectra of SUV bound samples were assigned to the N and C termini, correlating well with 
the regions that are unstructured in both the SDS and LPPG bound samples. The remainder of 
the protein is, as expected from the other mimetics, helical.  Thus all evidence consistently 
reports a secondary structure change throughout approximately one-third of the protein.  Like 
ENSA, the homologous protein ARPP-19 (~87% sequence homology) was also reported to be 
largely unstructured in solution (36). Given the strong sequence similarity between ENSA and 
ARPP-19, it is likely that ARPP-19 undergoes a similar conformational change upon lipid 
binding.    
5.6.2 The helical regions of lipid-bound ENSA are rich in basic residues  
Like other peripheral membrane proteins (37), ENSA contains large numbers of positively 
charged residues and preferentially binds lipids that contain anionic head-groups. The four 
helices that form in the membrane-bound state correspond to regions of the protein rich in 
positively charged amino acids. For example, helix 1 contains residues K36 and K38; in 
addition, R31 and K40 are at either end of the helix. The second and third helixes are rich in 
basic residues (K56, R57, K60, K63, K74, K76, K78). Likewise, the fourth helix contains R106, 
K107 and K114.  
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The involvement of positively charged amino acids likely accounts for the higher affinity of 
ENSA for lipids with anionic head groups, as illustrated by comparison of the spectra in complex 
with anionic SDS and zwitterionic DPC micelle-bound ENSA. Both detergents have the same 
length side chain and form micelles of ~20 kDa. While CD data indicated that binding to both 
mimetics increased the helical content of ENSA, the SDS bound state showed a more robust 
change to helical conformation (Figure 4A), in agreement with data obtained for LPPG, also 
bearing an anionic head-group.  In the NMR data, additional resonances were observed for the 
SDS micelle-bound sample (~110) than for the DPC bound sample (~75), and the resonances in 
the DPC-bound state were broader, which we attribute to intermediate exchange of the helices on 
and off the micelle. 
5.6.3 PKA phosphorylation may regulate the ENSA-AS interaction  
As previously shown (24), AS must be in a helical conformation in order to interact with 
ENSA, and here we have shown that ENSA also adopts a helical conformation as a prerequisite 
to AS binding. Here we extended upon this idea by evaluating the role of phosphorylation in 
ENSA-AS interactions. Phosphorylation is a common mechanism for regulation of protein-
protein interactions, and it is known that PKA phosphorylates S109 of ENSA (7). Thus we 
investigated the S109E mutant, a mimic of phosphorylated ENSA, and found that the fourth 
helix was disrupted and interactions with AS were significantly attenuated.  Chemical shift 
perturbation measurements indicated that the binding of AS to wild type ENSA primarily 
involves ENSA residues 28 to 36 and 88 to 97 (Figure 8), with smaller but still significant 
perturbations involving residues near S109. In contrast, no chemical shift perturbations of 
significance are observed in the S109E mutant of ENSA upon titration with AS.  
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5.6.4 Significance of lipid-binding to ENSA function   
K-ATP channels are found at the plasma membrane and at intracellular membranes including 
the endoplasmic reticulum, secretory granules, and mitochondrial membranes (38).  The SUR1 
and SUR2 regulatory subunits of K-ATP channels are oriented toward the cytoplasmic 
membrane face, and sulfonylurea drugs are thought to exert their effects intracellularly after first 
crossing the plasma membrane (39).  Likewise, ENSA is localized to the cytoplasm, where it is 
proposed to bind the SUR subunits and thereby modulate the K-ATP channel conductance (8, 9). 
Here we show that ENSA is also a lipid-binding protein, and that lipid interactions alter folding. 
We propose that the local membrane environment may regulate the interaction between ENSA 
and the SUR subunits of the K-ATP channel.  
5.7 Conclusion 
Here we have demonstrated that ENSA belongs to the class of intrinsically unstructured 
proteins (IUPs), which show little to no tertiary structure in isolation, but assume function in 
concert with a conformational change induced by interaction with target molecules. IUPs thereby 
exhibit biological properties that are not found in their highly structured counterparts. For 
example, IUPs can bind to multiple target molecules due to the plasticity of their structure (40). 
Induction of tertiary structure upon target binding can enhance specificity while keeping the 
binding affinity low (40), enabling interactions with multiple partners, and sometimes producing 
disparate physiological effects. Because of these properties, IUPs often display complex 
regulatory properties in signaling networks (41). 
In the case of ENSA, published studies suggest a role in the regulation of K-ATP channels, 
which are central to the physiological regulation of insulin secretion (2). Other studies, including 
our own, implicate ENSA in brain physiology (13, 24), where its loss is associated with 
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neurodegeneration (11, 12). We propose that ENSA may participate in multiple physiological 
processes, involving multiple binding partners, by virtue of its intrinsic structural plasticity. 
ENSA may partner functionally with AS (also a lipid-stabilized IUP (25)) in neural tissue, to 
subserve a neural-specific function and yet also partner with other molecules in different cellular 
contexts. As with many other regulatory proteins, these interactions are modified by 
phosphorylation. The structural data reported here begin to clarify the importance of 
environmental effects on ENSA structure and will facilitate a better understanding of the role 
ENSA plays in diverse processes from insulin secretion to neurodegeneration.  
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CHAPTER 6 
Calcium-induced clustering of phosphatidylserine in mixed lipid 
bilayers observed by SSNMR 
6.1 Notes and Acknowledgements 
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6.2 Abstract 
 Membranes play key regulatory roles in biological processes, with bilayer composition 
exerting marked effects on binding affinities and catalytic activities of a number of membrane-
associated proteins. In particular, proteins involved in diverse processes such as vesicle fusion, 
intracellular signaling cascades and blood coagulation interact specifically with anionic lipids 
like phosphatidylserine in the presence of calcium ions. Calcium is known to induce clustering of 
phosphatidylserine in mixed phospholipid bilayers, yet little is known about the roles of 
phospholipid clustering or headgroup conformation in these important biological processes. In 
this study, we used magic angle spinning (MAS) solid-state NMR (SSNMR) to obtain site-
resolved insights into the structure of lipid bilayers containing isotopically labeled serine 
headgroups in the context of mixed phosphatidylserine-phosphatidylcholine membranes. Here 
we report on Ca2+-induced conformational changes of phosphatidylserine in mixed bilayers using 
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both liposomes and Nanodiscs, a nanoscale membrane-mimetic. Site-resolved multidimensional 
correlation SSNMR spectra of bilayers containing 13C, 15N-labeled phosphatidylserine 
demonstrate that Ca2+ ions promote the stabilization of two major phosphatidylserine headgroup 
conformations, which are well resolved in 2D 13C-13C, 15N-13C and 31P-13C spectra. The data 
shows these two conformations are within 6 Å of each other. Results also show the effect that 
Ca2+-PS interactions have on lipid dynamics and bulk properties of nanometer-scale bilayers.   
6.3 Introduction 
A wide variety of biological processes take place on membrane surfaces, and many of these 
are mediated by Ca2+-dependent interactions with anionic phospholipids like phosphatidylserine 
(PS1).  Calcium ions can play various roles in these membrane-associated processes, including 
binding of Ca2+ to proteins (enhancing their ability to interact with the membrane surfaces) 
and/or the bilayer itself (altering the membrane surface presented for protein binding).  As an 
example, Ca2+-triggered vesicle fusion is coupled to Ca2+-dependent synaptotagmin binding to PS 
in the bilayer.  Synaptotagmin-1 binds Ca2+ ions with low affinity in its two C2 domains (1), but 
the Ca2+-binding site is completed by interactions with PS, thus enhancing Ca2+ affinity and 
promoting protein-membrane interactions (2).  The presence of PS in liposomes is required for 
synaptotagmin C2 domains to confer Ca2+ stimulation on SNARE-dependent liposome fusion 
(3).  It has also been suggested that Ca2+ plays an additional role in membrane fusion by directly 
interacting with the headgroups of membrane phospholipids, thus bridging the two opposing 
bilayers (4-6).  Another example is protein kinase C (PKCα), a ubiquitous signaling protein that 
binds preferentially, via its C2 domain, to membranes containing PS and phosphatidylinositol-
4,5-bisphosphate (PIP2).  While the PIP2 binding site has no direct interactions with Ca2+, PS 
interacts directly with two ligated Ca2+ ions in the C2 domain (7-9).  In the absence of Ca2+ 
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and/or PS, PKCα does not bind plasma membranes and therefore cannot readily interact with and 
phosphorylate its membrane-embedded protein targets. 
Other examples include several serine proteases in the blood clotting systems that bind, via 
their γ-carboxyglutamate rich (GLA) domains, to PS-containing membranes in a Ca2+-dependent 
manner (10-13). This binding interaction enhances the enzymatic activities of blood clotting 
proteases by many thousand-fold (10, 14).  The Ca2+-dependent association of GLA domains 
with PS-containing membranes is thought to be mediated, at least in part, via coordination of 
Ca2+ ions between negatively charged GLA residues and PS headgroups (15-17). 
It has also been shown that membrane-binding proteins and plasma Ca2+ concentrations can 
induce clustering of PS into membrane microdomains (18, 19), which may act as target regions 
to enhance activities such as cell signaling and blood coagulation. Structures of PS headgroups 
exist only for samples in the absence of Ca2+ (20), although previous NMR studies have shown 
that Ca2+-PS interactions in mixed bilayers cause conformational changes in PS headgroups (21, 
22) a detailed molecular picture of exactly how Ca2+ ions interact with PS molecules at a 
membrane surface has yet to emerge. An understanding of how Ca2+ ions affect PS-containing 
lipid bilayers is an important step toward elucidating the molecular details of a variety of Ca2+-
dependent protein-membrane complexes. 
In this study, we investigate the interactions of Ca2+ with PS-containing lipid bilayers using 
magic angle spinning (MAS) solid-state NMR (SSNMR) studies that employ two membrane 
mimetics, liposomes and Nanodiscs.  Nanodiscs are discoidal phospholipid bilayers of 8 nm-
diameter containing ~67 lipids per leaflet which are wrapped and stabilized by two molecules of 
an amphipathic helical protein termed membrane scaffold protein (MSP) (23-26). There are 
several examples in the literature that have effectively used the Nanodisc system as a membrane 
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mimetic in membrane protein interactions (16, 27) and SSNMR studies of membrane protein 
structures (28-30). One advantage of the Nanodisc system is that the structural integrity of the 
Nanodiscs persists with up to 90% PS in the bilayer, as opposed to liposomes which cannot 
tolerate more than 40% PS in the presence of Ca2+.  For these reasons, this system is the ideal 
experimental platform for investigating Ca2+-PS interactions on a membrane surface by SSNMR. 
In the present study, the serine headgroup of PS has been isotopically labeled and 
incorporated into the lipid bilayers, allowing for high resolution NMR spectra of PS headgroup 
moieties interacting with Ca2+ ions. Our results indicate that Ca2+ ions promote the formation of a 
liquid-ordered phase, producing rigid conformations for PS headgroups.  Mobility of the lipid 
acyl chains are not as affected by interactions with Ca2+ ions as the headgroups, although 
alteration of the phase transition behavior of the bilayer by Ca2+-PS interactions is shown. 
Furthermore, we report carbon, nitrogen and phosphorous chemical shift values for two Ca2+-
induced PS conformations as well as intermolecular distances between the two PS conformations 
in the bilayer. These observations are consistent with Ca2+-induced clustering of membrane-
incorporated PS molecules. 
6.4 Experimental Procedures 
6.4.1 Isotopically Labeled POPS   
In a modification of the method of Iwasaki, et al. (31), phospholipase D from Streptomyces 
(PLD; Sigma-Aldrich, St. Louis, MO) was used to replace the choline headgroup of POPC (1-
palmitoyl-2-oleoyl-phosphatidylcholine) with U-13C, 15N-L-serine (Cambridge Isotopes 
Laboratories, Andover, MA) to yield POPS (1-palmitoyl-2-oleoyl-phosphatidylserine) that was 
isotopically labeled in the serine headgroup (termed POPS*).  Briefly, 5 µg/mL PLD was added, 
with stirring, to a mixture of 1.5 M 13C, 15N-serine, 36 mg/mL POPC (Avanti Polar Lipids, 
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Alabaster, AL) and CaSO4 in 50 mM sodium acetate buffer, pH 5.6, and allowed to react 
overnight at 42 °C.  The supernatant was collected by centrifugation, flushed with nitrogen gas 
and stored at 4 °C for use in subsequent reactions.  The pellet was washed with water and re-
suspended in 2:1 hexane:ethanol (5 mL per 1 mL original reaction volume), followed by water 
(1/4 the volume of hexane:ethanol) and 1 N HCl (1/10 the volume of the water). After vortexing, 
the hexane phase was collected, and the aqueous phase and pellet were extracted with additional 
hexane.  The pooled hexane phases were dried under vacuum and POPS* was purified by CM52 
chromatography (32).  Purity of POPS* was evaluated by two-dimensional thin-layer 
chromatography, using 90:54 chloroform:methanol for the first dimension and 65:25:4 
chloroform:methanol:water for the second dimension.  When necessary, POPS* was further 
purified by flash silica chromatography developed with 90:40:12:2 chloroform:methanol:acetic 
acid:water.  Purified POPS* was stored in chloroform and its concentration determined by 
inorganic phosphate analysis after complete hydrolysis.  POPS* purity and the level of 13C, 15N-
serine incorporation was verified by HSQC solution NMR in chloroform. 
6.4.2 Nanodisc Preparation   
Nanodiscs were prepared as previously described (25) using mixtures of POPC and POPS*.  
Briefly, dried phospholipids were suspended in Tris buffer containing a 2:1 molar ratio of 
deoxycholate:phospholipid and the mixture was sonicated.  MSP was added at a 67:1 molar ratio 
of lipid:MSP and incubated for 1-2 hours, after which detergent was removed using SM-2 
Absorbent Bio-Beads (BioRad, Hercules, CA) to allow Nanodisc self-assembly.  Nanodiscs were 
purified by size-exclusion chromatography (25), except that the buffer was 10 mM Tris-HCl pH 
7.4, 10 mM NaCl, with 2 mM CaCl2.  Samples were concentrated by centrifuging at 3000g in a 
Amicon Ultra 10000 NMWL centrifugal filter (Thermo Fisher Scientific, Waltham, MA) to 2-3 
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mM phospholipid (15-22 µM Nanodiscs), and the lyoprotectant, trehalose, was added in a 1:1 
molar ratio to phospholipid.  Samples were lyophilized and the powders (~50% Nanodiscs by 
weight) were packed into 3.2 mm SSNMR rotors, after which water was added (equal to ~50% 
of the dry weight of packed samples). 
6.4.3 Liposome Preparation   
Mixtures of dried POPC and POPS* (10 mg total) were suspended in 30 µL of 50 mM Tris-
HCl pH 7.4, 100 mM NaCl, 2.5 mM CaCl2 and sonicated until the solution was visually 
homogeneous, after which 1 mL of 2.5 mM CaCl2 was added and the solution was sonicated 
again.  Preparations of samples in the absence of Ca2+ were identical except for the inclusion or 
addition of CaCl2. Liposomes were collected by ultracentrifugation at 4 °C for 2.5 hours at 
250,000 rcf, and the pelleted liposomes were packed into 3.2 mm SSNMR rotors. 
6.4.4 Solid-State NMR 
SSNMR studies were performed on four-channel Varian InfinityPlus spectrometers. 
POPS*:POPC Nanodiscs spectra were acquired at 600 MHz with a Varian T3 1H-13C-15N 3.2 mm 
probe at an MAS rate of 10,000±3 Hz. The variable temperature gas was maintained at 90±10 
scfh flow, and the reported sample temperatures take into account thermocouple calibration and 
frictional heating due to MAS, as calibrated with ethylene glycol (33). All experiments utilized 
tangent ramped cross polarization (CP) (34) with TPPM (35) decoupling of the protons applied 
during acquisition and evolution periods on average at ~80 kHz. Data were processed with 
NMRPipe (36) with back linear prediction and polynomial baseline (frequency domain) 
correction applied to the direct dimension, and zero filling and Lorentzian-to-Gaussian 
apodization applied to each dimension before Fourier transformation; additional processing 
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parameters are located in the figure captions. Chemical shifts are referenced to adamantane (37). 
Peak picking and assignments were performed with Sparky (38). 
6.5 Results  
 6.5.1 Effects of Ca2+ binding on 13C chemical shifts  
 
Figure 6.1 One-dimensional 13C spectra of POPS*:POPC liposomes. 
(a) POPS structure is shown with 13C One-dimensional spectra of 30% POPS* 70% POPC liposomes (b) 
with 2 mM Ca2+, and (c) without calcium acquired on a 500 MHz (1H frequency) spectrometer. Both 
spectra were acquired with the same number of scans (4096) at -20 °C, below the liquid crystal phase 
transition, to remove spurious contributions from the natural abundance POPC headgroup. Both spectra 
were zero filled to twice the original data size and line broadened 0.2 ppm. 
Previous studies have shown that plasma Ca2+ concentrations can cause PS to cluster into 
microdomains (18, 19). Initial analysis of these microdomains began by comparing one-
dimensional 13C spectra of mixed POPS*:POPC bilayers and the effects Ca2+ has on the chemical 
shifts, which are sensitive to binding events and structural changes. One-dimensional CP 13C 
spectra at -20 °C (Figure 1) were acquired on liposomes containing 30% POPS*, 70% POPC in 
the presence and absence of 2.5 mM Ca2+. Signals due to natural abundance 13C on the fatty acyl 
  118 
chains are readily observed below 40 ppm (one resonance at ~132 ppm is ascribed to the olefinic 
carbons in the oleoyl chain) and consistent with previous SSNMR assignments of lipids in 
bilayers (39). Spectra of liposomes in the presence of 2.5 mM Ca2+ contain distinct 13C 
resonances (Figure 1b) from POPS* headgroups. Two resonances, at 66.26 and 67.91 ppm, are 
observed for the POPS* alpha carbon (Cα), and the POPS* beta carbon (Cβ) peak, at ~60 ppm, 
is broadened (line width 190 Hz) indicating two unresolved signals. Similarly, the POPS* 
gamma carbon (Cγ) (at ~174.2 ppm) resonance is also slightly broadened to 131 Hz, which, 
while not as dramatic as the Cβ, is still consistent with two unresolved signals. The appearance 
of two chemical shifts for the carbons in the PS headgroup is indicative of two distinct chemical 
environments for the PS in the presence of Ca2+ that are long lived on the NMR time scale (>5 
ms). This result is compatible with earlier studies (21, 22) that show PS headgroups, in mixed 
bilayers, adopt two conformations in the presence of Ca2+. In the absence of Ca2+ (Figure 1c), at -
20 °C, the POPS*:POPC  liposomes display very broad resonances from ~55 to ~67 and from 
~170 to ~180 ppm. These broad resonances are attributed to the PS headgroup adopting multiple 
confirmations leading to multiple chemical shift values. Spectra of these liposomes in the 
absence of Ca2+ at 10 °C (data not shown) contain only one chemical shift value for each POPS* 
carbon signal indicating the multiple conformations are in fast exchange on the NMR timescale 
(exchange between conformations is <5 ms). The liposomes with Ca2+ exhibit the same splitting 
of the POPS* Cα, and broadening of the POPS* Cβ and Cγ resonances in spectra acquired at 10 
°C as seen at -20 °C (not shown).  
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6.5.2 Ca2+-PS interactions observed in Nanodiscs  
 
Figure 6.2 One-dimensional 13C spectra of POPS*:POPC liposomes and Nanodiscs with Ca2+. 
13C One-dimensional spectra of (a) 10% POPS*, 90% POPC liposomes containing 2.5 mM calcium  (b) 
30% POPS*, 70% POPC Nanodisc containing 2 mM calcium and, (c) 70% POPS*, 30% POPC Nanodisc 
sample with 2 mM calcium.  All spectra were acquired at -20 °C with an MAS rate of 10.000 kHz on a 
600 MHz (H1 frequency) spectrometer; asterisks indicate a carrier frequency artifact at ~108 ppm. All 
spectra were zero filled to twice the original data size and line broadened 0.2 ppm. 
We investigated the effect of Ca2+ on PS headgroups using two different membrane 
mimetics: liposomes and Nanodiscs. Samples were prepared with 10%, 30% or 70% POPS* 
(balance = POPC). The 10% POPS* sample was prepared in liposomes while the 30% and 70% 
POPS* samples were prepared using the Nanodisc system. All samples were prepared in the 
presence of 2 mM Ca2+. One-dimensional 13C spectra were acquired for all three samples (Figure 
2). The spectra are consistent with the spectrum from Figure 1b, with identical chemical shifts 
observed for the POPS* headgroup carbons. These data show that the same Ca2+-induced PS 
conformations are present in both liposomes and Nanodiscs over a range of PS concentrations.  
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6.5.3 Ca2+-PS Interactions Alter the Phase Transition and Dynamics of Lipids within the Bilayer   
 
Figure 6.3 Relaxation measurements of Ca2+ bound PS. 
a) Normalized 1H T2 values of the bulk fatty acyl CH2 peaks of nanobilayers, as a function of temperature.  
Nanodiscs had either 100% POPC (squares with dashed lines) or 30%POPS*, 70% POPC (circles with 
solid lines) prepared in the presence of 2 mM Ca2+. The data was acquired over a temperature range of -20 
to 20 °C. Transition temperatures were determined using signals from the lipid side chains. 1H T2 values 
were used to fit the inflection point of the curve as a function of temperature.  The solid arrow just above 
the x-axis denotes the lipid phase transition for the 30%POPS*, 70% POPC Nanodiscs (~8 °C), while the 
dotted arrow denotes the phase transition for 100% POPC Nanodiscs (~3 °C). (b) 1H Hahn echo 
experiment was used to investigate the T2 of the methylene protons (8 and 11; Figure 1a) neighboring the 
olefinic bond at 25 °C. Plotted is the intensity of the methylene proton peak as a function of the echo 
time. A single exponential decay curve is shown fit to the data (using Spinsight 3.0). Both a single and bi-
exponential function were fit to the data. An F test of the single exponential and bi-exponential fits 
resulted in an F statistic of 1.00 confirming that the best fit is a single exponential decay. The T2 was 
calculated to be 14.1 ms.  
 
We investigated the dynamics of Ca2+-induced PS clustering by examining the change in the 
phase transition of the mixed POPS:POPC Nanodisc bilayers in the presence of Ca2+. 1H T2 
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values of directly detected 1H spectra over a ±20 °C temperature range reveal acyl chain 
dynamics as a function of temperature (Figure 3a). We confirmed the expected ~3 °C phase 
transition of pure POPC Nanodisc bilayers (Figure 3a) observed in previous differential scanning 
calorimetry measurements (40). Dynamics measurements on mixed lipid POPS*:POPC 
Nanodiscs with 2 mM Ca2+ (Figure 3a), display a broad (range of 30 °C) and slightly elevated 
phase transition in comparison to POPC Nanodisc. This effect has been reported previously 
using other membrane mimetics (41-43) and is attributed to the Ca2+-PS coordination. The acyl 
chain dynamics that dictate the 1H T2 report the transition as a bulk property; however, subtleties 
in the data arise from site-specific variations in dynamics along the acyl chain approaching the 
PS headgroup. 
An additional dynamics study was performed on the POPC Nanodisc bilayer to investigate 
the presence of a boundary layer of lipids whose lateral mobility would be severely restricted and 
distort the phase transition. The 1H T2 (at 25°C) of the methylene protons neighboring the 
olefinic bond (position 8 and 11 of Figure 1a), unique to the lipid acyl chain, were measured to 
prevent spurious contributions from MSP protons (Figure 3b). A single exponential fit best 
described (Figure 3b) the decay behavior indicating that all the lipids are mobile within the 
Nanodisc and diffuse freely. The interactions of lipids with the membrane scaffold protein occur 
in the rapid exchange regime and have a negligible effect on the phase transition.  
To further understand the dynamics of Ca2+ on the POPS*:POPC bilayers, a more detailed, 
site-specific investigation of the bilayer dynamics was performed. Site-specific dynamics 
measurements using SSNMR were acquired for POPS*:POPC Nanodisc bilayers utilizing the 
symmetry based recoupling sequence R1817 (44), which reports on amplitudes of motions on the 
microsecond and faster time scale. These studies show that the serine headgroups have very little 
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motional freedom over a temperature range of 20 °C to -30 °C in the presence of calcium ions 
(Figure 4); in contrast, the acyl chains’ motions are more varied over the same temperature 
range, becoming less mobile as the temperature is decreased. The R1817 sequence recouples the 
1H-13C-dipolar interactions and signal intensity measured as a function of time reports on the 
dynamics of the system. Observed here are the 1H-Cα and 1H-Cβ relaxation curves due to 1H-
13C-dipolar interactions of the POPS* headgroup at varying temperatures (Figure 4a,b). These 
time domain trajectories represent the rigid lattice limit of motion (S≈0.95) over a range of 
temperatures from 20 °C to -30 °C. This shows that, both above and below the phase transition, 
there is very little to no motion in the headgroup. However, the same interactions of the CH2 
groups of the acyl chain show a much larger dependence on temperature changes with an order 
parameter that goes from 0.3 to 0.8 as the temperature goes from 20 °C to -30 °C (Figure 4c).  
 
Figure 6.4 Dynamics of PS headgroups and acyl chains. 
Dynamics of phospholipid headgroups and acyl chains in 30%POPS*, 70% POPC Nanodiscs in the 
presence of 2 mM Ca2+ as a function of temperature.  1H-13C dipolar trajectories (plotted as normalized 
intensities) are presented at the indicated temperatures for (a) the Cα  (CH2) of the serine headgroup, (b) 
the Cβ (CH) of the serine headgroup, and (c) the bulk CH2 (resonance at 32 ppm of Figure 2b) group of 
fatty acyl chains, recoupled using R1817. The PS headgroup maintains an order parameter near the rigid 
lattice limit (S=X), while the acyl chain motion is substantially activated (S= X to Y) over the range from 
-30 °C to +20 °C.  
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6.5.4 Two-dimensional Spectra of POPS*:POPC Nanodiscs  
 
Figure 6.5 Two-dimensional SSNMR spectra of 70% POPS*, 30% POPC Nanodiscs. 
Ca2+ induces two conformations of PS headgroups as evidenced by two-dimensional SSNMR. 70% 
POPS*, 30% POPC Nanodiscs were prepared with 2 mM Ca2+ and spectra were acquired with an MAS 
rate of 10 kHz on a 600 MHz (1H frequency) spectrometer. 13C-13C 2D DARR spectra with (a) 25 ms 
DARR mixing acquired at -30 °C and (b) with 200 ms DARR mixing acquired at 5 °C. For both a+b 
panels, the insets are expansions of the Cα-Cβ  regions. The phosphorus and nitrogen chemical shifts of 
the two Ca2+-induced conformers are also well resolved as shown in expansions of the serine Cα-Cβ and 
Cγ regions of (c) 15N-13C TEDOR spectrum with 6.4 ms REDOR mixing acquired at -10 °C and (d) 31P-
13C TEDOR spectrum with 2.4 ms of REDOR mixing acquired at -20 °C. All spectra were zero filled to 
twice the original data size. The 13C-13C two-dimensional spectra were line broadened 0.2 ppm in both 
dimensions. 
Using a series of two-dimensional spectra (Figure 5) acquired on the 70% POPS*, 30% PPC 
Nanodisc sample in the presence of 2 mM Ca2+ we site specifically assign the chemical shifts of 
the two PS headgroup conformations and report on intra and intermolecular correlations of the 
two conformers. We acquired 13C-13C, 15N-13C, and 31P-13C two-dimensional spectra (Figure 5) 
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and assigned the chemical shifts for both PS spin systems (Table 1) for all carbon, nitrogen and 
phosphorous atoms. We have labeled the two spin systems PS1 and PS2 (Table 1), based on 
appearance of chemical shifts. The 13C-13C two-dimensional spectra were acquired with 25 and 
200 ms of DARR mixing (45, 46) (Figure 5a,b). The carbon signals arising from the natural 
abundant 13C on the acyl chains are again seen along the diagonal below 40 ppm; no cross peaks 
are observed or expected from these resonances. 13C-13C spectra with 25 ms DARR mixing 
(Figure 5a) show intramolecular Cα-Cβ cross peaks of both PS1 and PS2. The ratio of integrated 
intensity of the PS1:PS2 intramolecular Cα-Cβ cross peaks is 52:48, indicating that the PS is 
divided approximately equally between the two conformations. Additionally, intramolecular Cα-
Cγ and Cβ-Cγ correlations are observed for both conformations. Similar intramolecular 
correlations are observed between both 15N and 31P of the two PS conformations and the three 
carbon resonances (Cα, Cβ, Cγ) in the 15N-13C and 31P-13C two-dimensional TEDOR (47) spectra 
(Figure 5c,d).  
Chemical Shift Value (ppm) 
 Cα Cβ Cγ N P 
PS1 67.91 60.18 174.38 41.82 -6.29 
PS2 66.26 59.55 174.19 38.43 -7.40 
Table 6.1 Carbon, nitrogen and phosphorous chemical shift values for PS headgroups bound to 
Ca2+ in mixed POPS:POPC bilayers. 
Intra and intermolecular correlations in the two-dimensional spectra reveal structural insights 
of individual PS headgroups and on clustering of the two conformations, respectively. Both 
TEDOR (heteronuclear) (47) and DARR (homonuclear) (45, 46) pulse sequences take advantage 
of strong dipolar interactions present in SSNMR. The dipolar interaction is a through space 
interaction and therefore inherently contains information on distance (∝1/r3) that is reflected in 
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the intensity of the cross peaks as a function of mixing time. Using the 13C-13C and 13C-31P 
dipolar interactions, distances up to ~6 Å can be measured between atoms. The 31P-13C TEDOR 
spectrum (Figure 5d) contains P-Cγ and P-Cβ intramolecular cross peaks with differing 
intensities for the PS1 and PS2 conformation. The intensities of the cross peaks are directly 
related to carbon-phosphorous distances. Preliminary distance data (not shown) collected with 
31P-13C TEDOR spectra indicate that Cγ-P distance in PS1 is ~4 Å. The other conformation, PS2, 
adopts a more extended structure with an approximate Cγ-P distance of ~5 Å. The preliminary 
data on the PS1 and PS2 conformations do not exclude the two headgroup conformers solved 
previously at pH 7.5 for 1,2-dimyristoyl-phosphatidylserine (DMPS) in dodecylphosphocholine 
(DPC) micelles (20). The two conformations solved previously were done at varying pH, in the 
presence of Na2+ and are in fast chemical exchange (20, 48). The data presented here suggest that 
the Ca2+ coordination does not necessarily change the headgroup structures, but there is a definite 
change in the exchange rate between headgroups. Our data show that in the presence of Ca2+ the 
PS1 and PS2 are in slow chemical exchange on the NMR time scale. More structural 
investigations are underway to solve atomically resolved structures for PS1 and PS2 
conformations in the presence of Ca2+. 
Finally, using 13C-13C DARR spectrum with 200 ms mixing, and the 31P-13C TEDOR 
spectrum (Figure 5b,d) we show direct evidence of Ca2+ induced PS clustering. The 13C-13C 
DARR spectrum with 200 ms mixing (Figure 5b) shows a cross peak between the Cα of PS1 and 
the Cα of PS2. Additionally, the 31P-13C TEDOR spectrum (Figure 5d) has an intermolecular 
correlation from the phosphorous of PS2 to the Cα of PS1. These intermolecular cross peaks are 
evidence of a distance of 5-6 Å between PS1 and PS2 and give insight into the geometric 
arrangement of the PS clusters. These distance measurements are preliminary and more distance 
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constraints coupled with angular restraints are necessary for a full calculation of an atomically 
resolved structure of the Ca2+ induced PS microdomain.  
6.6 Discussion 
 Calcium interactions not only induce specific conformations of the PS headgroup but also 
arrange the two conformations within ~6 Å of each other. The spectra show the presence of two 
conformations of PS in the presence of Ca2+. These findings are consistent with previous studies 
(21, 22) and extend on the current knowledge with site-specific assignments of the two 
conformations, PS1 and PS2, for headgroup nitrogen, carbon and phosphorous resonances (Table 
1). Previous work has reported on the structure of PS in the presence of Na+ in mixed 
DPC:DMPS micelles (20). Sanson et al. reported two dominate PS species and focused on the 
conformation of the glycerol backbone. No angular or distance data was specifically reported for 
the serine headgroups. This makes comparing our preliminary distance data with previous 
structures difficult. Therefore, we cannot exclude or confirm the existence of these structures in 
the Ca2+ induced PS-clusters. What is of significant note is a major change in the dynamics of the 
conformations in the presence of Ca2+. PS conformers in the presence of Na+ are in fast chemical 
exchange and are likely to have intermediate structures during exchange (20, 48). We note that 
this fast exchange between conformations, in the absence of Ca2+, results in only one chemical 
shift value for the three carbons (Cα, Cβ, Cγ) above the phase transition and broad signals below 
the phase transition (Figure 1c). Addition of calcium to the system coordinates PS into two 
distinct conformations, changing the dynamics of the system, so that PS1 and PS2 are long lived 
on the NMR timescale.  
Additionally, we report on the intermolecular organization of the PS1 and PS2 conformers. 
Two-dimensional 13C-13C and 31P-13C spectra revealed cross peaks between PS1 and PS2 
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conformations, which indicate that the two conformers are within ~5-6 Å of each other. POPS 
lipids are split evenly between the two conformers, suggesting that each cluster contains an 
approximate two-fold symmetric organization of PS headgroups within 6 Å of each other around 
Ca2+ coordination centers. This conclusion is consistent with binding data and molecular 
dynamics simulations that show a 2:1 ratio of PS:Ca2+ (49-51); though, the exact stoichiometry 
of the coordination center is yet to be determined.  
The results of the dynamics studies using the Nanodisc system demonstrate that Ca2+ 
interactions with mix POPS:POPC bilayers are consistent with previous studies using liposomes 
(21, 22, 43, 52). Our site-specific dynamics data (Figure 4) show interactions of Ca2+ with mixed 
POPS:POPC bilayers cause the PS headgroups to become highly ordered, while, the acyl chains 
are only slightly affected by this ordering. This detailed investigation of the dynamics explains 
the increase in the liquid-crystalline to solid-gel phase transition of these mixed bilayers 
presented earlier (Figure 3a) and observed by others (41-43). As Browning et al. reported (52), in 
the presence of Ca2+, the PS headgroup does not dominate the properties of the hydrophobic tails 
in the liquid-crystalline state. The restricted motion of the headgroup translates minimally to the 
carbons on the acyl chains near the glycerol backbone causing slight increase and broadening in 
the transition temperature. This is what we would expect in the model where headgroups in PS 
microdomains are locked in position by the coordination of Ca2+; while the acyl chains 
experience only slight restrictions on their motion. We propose that Ca2+ induces a liquid-ordered 
phase (53) in which there is some order to system (in the PS headgroups) but the acyl chains 
remain disordered as in a liquid phase. We picture this as a microdomain of PS where diffusion 
of PS within the microdomain is likely and the microdomain, as a whole unit, is free to diffuse 
laterally in the bilayer. This picture is consistent with the dynamics data including the increase in 
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the liquid-crystalline to solid-gel phase transition temperature as well as a broadening of this 
transition.  
The results of Ca2+ induced PS-clustering into microdomains on Nanodisc samples and 
liposomes samples are identical. This investigation demonstrates that the Nanodisc system is an 
excellent tool for investigating Ca2+ interactions with biological membranes and has several 
advantages over liposomes.  Liposomes have short sample lifetimes, do not tolerate temperature 
fluctuations well and are limited in the range of PS concentrations available in the presence of 
Ca2+. In contrast, Nanodiscs are thermostable and have a sample lifetime measured in years and 
have advantages over liposomes in ease of SSNMR sample preparation. Nanodisc samples are 
lyophilized prior to packing into a SSNMR rotor. This allows for the efficient transfer (~80%) of 
powder to the SSNMR rotor verses a gelatinous liposome pellet. After lyophilization the 
Nanodiscs are rehydrated to 50% by mass with deionized water. Liposomes do not tolerate 
lyophilization well and transfer of the centrifuged liposome pellet into the SSNMR rotor is ~50% 
efficient.  Furthermore, liposome samples prepared for SSNMR are only stable for 1-2 weeks, 
while Nanodisc samples have long lifetimes (years). One key advantage of the Nanodisc system 
is that it allows facile control of the lipid content on the nanoscale. Liposomes with high PS 
content are unstable in the presence of calcium, forming PS-Ca2+ cochleate in samples that 
contain >40% PS (42, 54). Nanodiscs allow for as much as 90% PS to be incorporated into the 
membrane bilayer in the presence of Ca2+. The increased stability and inherent control of lipid 
composition over a range of PS concentrations allows for the effective isolation of PS-
microdomains. These domains have locally high PS concentrations and are where key biological 
interactions take place (18, 19).  
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In conclusion, we have demonstrated that Ca2+ interacts with PS in membrane bilayers to 
form liquid-ordered microdomains. The interaction forms a symmetric organization of the PS in 
the lipid bilayer, which is free to diffuse laterally through the bilayer. This presents a unique 
binding site for PS-Ca2+ dependent membrane proteins. Nanodiscs are an excellent membrane 
mimetic to investigate these structures. Current work in the lab is focused on completing analysis 
of distance and angular restraints to use in calculations of an atomically resolved structure of the 
PS microdomains in membrane bilayers. Structural understandings of these PS microdomains 
will give insight into many biologically relevant membrane-protein interactions that are 
dependent on presence of Ca2+ and PS containing membranes. 
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CHAPTER 7 
Backbone 1H, 13C, and 15N resonance assignments of the extracellular 
domain of tissue factor 
7.1 Notes and Acknowledgements 
 This chapter was adapted from John M. Boettcher, Mary Clay, Benjamin J. LaHood, 
Jamse H. Morrissey, and Chad M. Rienstra (manuscript in preparation). This work was supported 
by NIH grants R01 GM075937 and R01 HL47014. 
7.2 Abstract 
13C, 15N, and 1H backbone chemical shift assignments are presented for the extracellular 
domain of tissue factor. Tissue factor is the integral membrane protein that initiates blood 
coagulation through the formation an enzymatic complex with the plasma serine protease, factor 
VIIa.    
7.3 Biological context 
In normal hemostasis and most thrombotic diseases, blood clotting is triggered upon the 
assembly of the cell-surface complex of tissue factor (TF) and activated factor VII (FVIIa) (1). 
TF is a type-I integral membrane protein found on the surface of a variety of cells outside the 
vasculature (2), while FVIIa is a plasma serine protease. The TF:FVIIa complex can be 
considered a two-subunit enzyme, with FVIIa as the catalytic subunit and TF the essential 
regulatory subunit; it triggers the clotting cascade via limited proteolysis of FIX and FX, which 
ends in the formation of a fibrin clot.  
A 263-residue integral membrane protein, human TF is composed of three domains: the 
cytoplasmic domain (residues 243-263), a membrane spanning helix (residues 220-242) and the 
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extracellular domain (residues 1-219) which in turn is composed of two fibronectin type III 
domains (3). The cytoplasmic domain may function in signaling, and the single transmembrane 
helix anchors the protein in the membrane bilayer. The isolated extracellular domain, referred to 
as soluble tissue factor (sTF), constitutes the bulk of the protein (~83%) and is the domain that 
allosterically activates FVIIa. Crystal structures are available for sTF (4) as is a 1H-15N HSQC 
spectrum of sTF (5), although no site-specific resonance assignments have been reported for sTF 
or the full-length, membrane-bound TF. Here we report the assignment of ~90% of the backbone 
resonances in sTF. These site-specific chemical shift assignments will allow for further 
investigations into conformational changes of sTF upon interaction with FVIIa and/or the 
membrane bilayer. 
7.4 Methods and experiments 
7.4.1 Recombinant Protein Expression and Purification 
 2H,13C,15N-labeled human sTF protein was expressed in  T7 Express E. coli cells (New 
England BioLabs, Inc., Ipswitch, MA) from plasmid pJH677. Detailed expression conditions will 
be communicated elsewhere (manuscript in preparation); briefly, a starter culture was grown at 
37 °C to OD600 = 6 in a modified Studier MDG medium (6) at natural isotopic abundance. The 
bacteria were then harvested and resuspended in 3 volumes of fresh medium containing 
2H,13C,15N-BioExpress (Cambridge Isotopes Laboratories, Inc., Andover, MA), U-13C-glycerol 
and phosphate. Specifically, BioExpress (10X stock solution) was diluted to 1X with 100 mM 
phosphate buffer at pH 7.5. U-13C-glycerol was added at 2 g/L and the culture was grown at 25° 
C until the OD600 reached ~3. Expression of sTF was induced with 20 µM isopropyl β-D-1-
thiogalactopyranoside for 24 hours. The cells were harvested, sTF released by osmotic shock, 
and the cell debris pelleted. The supernatant was purified with Q-Sepharose, Ni2+ affinity and gel 
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filtration chromatography (HiPrep 16/160 Sephacryl S-200, GE Biosciences). This resulted in 
>95% purity, and a yield of 70-100 mg/L sTF. All purification solutions contained 1H2O, in order 
to exchange backbone amides. 
7.4.2 NMR Spectroscopy 
 Solution NMR spectra were acquired at the School of Chemical Sciences NMR Facility 
(University of Illinois at Urbana-Champaign) on Varian INOVA 600 MHz and 750 MHz 
spectrometers equipped with a 5 mm, triple resonance (1H-13C-15N) triaxial gradient probes, using 
VNMRJ version 2.1B with the BioPack suite of pulse programs.  Spectra were acquired at 35 °C 
on back-exchanged 2H, 13C, 15N-sTF samples (1 mM in a 50 mM phosphate buffer, pH 6.5, 
containing 50 mM NaCl and 10% D2O (v/v)). 2D 1H-15N TROSY spectra were measured for an 
average of two hours per spectrum, digitizing 512 points in the indirect 15N dimension (t1max = 
232 ms). The standard suite of TROSY-based heteronuclear triple resonance 3D spectra (HNCO, 
HN(CA)CO, HNCA, HNCACB, HN(CO)CA) was utilized to establish correlations among 
backbone resonances of the sTF sample. Measurement times for the 3D spectra were 12 to 48 
hours. Spectra were processed with NMRPipe (7) and analyzed in Sparky (8). 
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Figure 7.1 15N-1H 2D TROSY-HSQC NMR spectrum of sTF. 
15N-1H 2D TROSY-HSQC NMR spectrum of sTF acquired at 600 MHz (1H frequency) (in phosphate 
buffer, 50 mM NaCl, pH 6.5, 35 ºC).  213 of the expected 218 resonances are resolved. The spectrum was 
processed with sine bell apodization and zero filled to at least double the original size in both dimensions. 
Subsets of the available assignments are labeled. 
7.5 Extent of assignments and data deposition 
A standard set of triple resonance TROSY based spectra was used to complete ~90% of the 
HN, N, Cα, Cβ, C’ backbone assignments of sTF; this includes >95% of all the HN, N, Cα, C’ 
and ~60% of the Cβ. The assignments are deposited in the BMRB under accession number XXX 
(for release upon publication). The 1H-15N TROSY spectrum (Figure 7.1) is qualitatively 
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consistent with previously published sTF 1H-15N HSQC spectra, which were not assigned (5).  
The improved sensitivity and resolution enabled us to assign 213 of the expected 218 amide 
resonances (excluding the 9 prolines but including the 10 residue His tag). We were not able to 
make unambiguous assignments of residues 77, 78 and 137, or residues 229 and 230 (within the 
His tag). Residues 77 and 78 precede a proline, and resumption of the backbone walk was further 
complicated by relatively weak signal intensities throughout this portion of the protein. Residue 
137, in a flexible loop, was also missing in the 3D experiments and therefore could not be 
assigned.  
 
Figure 7.2 Secondary structure elements of sTF identified by chemical shift analysis. 
Secondary structure elements of sTF identified by TALOS+ (9). Plotted are the Phi (Φ) (black circles) 
and Psi (Ψ) (gray squares) backbone torsion angles as predicted by TALSO+ (9) with error bars. Along 
the x-axis is a cartoon representation of the secondary structure based on the crystal structure (2HFT (4)). 
The results of the secondary structural analysis show the majority of sTF is β-strand with three α helices 
(shaded gray boxes), in agreement with the crystal structure. 
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TALOS+ (9) analysis of the secondary structure (Figure 7.2) by NMR illustrates the α-
helical and β-strand positions in good agreement with the crystal structure (4). We also report 
data for residues 87 to 90, 161, 162 and 212 to 219 that are not in the crystal structure due to the 
lack of electron density (4). The TALOS+ (9) analysis shows that residues 87 to 90 and 212 to 
219 are in unstructured, dynamic regions, while residues 161 and 162 are both in an extended 
conformations. 
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CHAPTER 8 
Structural investigations of Tissue Factor, a blood coagulation 
protein 
8.1 Notes and Acknowledgements 
This chapter was adapted from a manuscript in preparation by John M. Boettcher, Mary 
Clay, Benjamin J. LaHood, Rebecca Davis-Harrison, James H. Morrissey, and Chad M. Rienstra. 
This work was supported by the National Institute of General Medical Sciences, NIH 
(GM075937-01to C.M.R.), the National Heart Lung and Blood Institute, NIH (HL47014 to 
J.H.M.), and by the American Heart Association (0920045G to R.D.H.). 
8.2 Abstract 
The formation of the cell-surface complex of tissue factor (TF) with activated factor VII 
(FVIIa) initiates blood clotting in normal hemostasis. It is well known that TF allosterically 
activates FVIIa, though; how TF dramatically increases the activity of FVIIa is not well 
understood. The TF:FVIIa complex triggers the clotting cascade through activation of factor X 
and factor IX. Residues in both TF and FVIIa, near the membrane surface, are reported to form 
an exosite for substrate binding. Several crystal structures and mutagenesis studies have given 
insights into the TF:FVIIa complex, yet, a complete understanding of essential interactions are 
lacking. The available crystal structures were solved for the soluble, extracellular domain of TF 
(sTF), in the absence of membranes. In addition to missing membrane interactions, the structures 
lack information on many residues reported to be involved in vital allosteric and substrate 
interactions. Understanding the conformational changes of the key TF residues involved in 
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allosteric activation and substrate binding will allow a more thorough understanding of the 
TF:FVIIa complex. Here we report the sTF chemical shift assignments of sTF for 82% of the 
residues using solid-state NMR, which agree well with previously reported solution chemical 
shifts for sTF. These data are also compared to initial two-dimensional spectra acquired on 
membrane bound TF and we report on an interaction between a loop in extracellular domain of 
TF and the membrane surface involved in the TF:FVIIa substrate binding site.  
8.3 Introduction 
In normal hemostasis and most thrombotic diseases, blood clotting is triggered upon the 
assembly of the cell-surface complex of tissue factor (TF) and activated factor VII (FVIIa) (1). 
TF is a type-I integral membrane protein found on the surface of a variety of cells outside the 
vasculature (2). The ligand for TF is factor VII (FVII), a plasma serine protease that circulates 
mostly in the zymogen form, although a little less than 1% circulates as FVIIa (3). Both FVII and 
FVIIa bind to TF with similar affinities (4). Once bound to TF, FVII is rapidly converted to 
FVIIa via cleavage of a single peptide bond. The resulting TF:FVIIa complex is a two-subunit 
enzyme, in which FVIIa is the catalytic subunit and TF is the essential regulatory subunit. 
TF:FVIIa triggers the clotting cascade via limited proteolysis of factor IX (FIX) and factor X 
(FX).  
X-ray crystal structures of a truncated, soluble form of tissue factor (sTF; composed of just 
the extracellular domain) have been determined (5-9) as well as complexes of sTF with FVIIa 
(10, 11). Previous mutagenesis studies have identified the residues of sTF that interact with 
FVIIa (12) and the complex structures reveal a large surface area of interaction between sTF and 
all 4 domains of FVIIa (10, 11). Though, it is well understood that these interactions induce 
conformational changes in the FVIIa active site; precisely how TF dramatically enhances the 
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enzymatic activity of FVIIa is not completely understood (13). Membrane-anchoring of TF is, 
however, absolutely required for full procoagulant activity (14). 
TF contains two fibronectin type III domains. The C-terminal fibronectin type III domain of 
sTF contains key residues, including K165 and K166, that are necessary for the binding of 
TF:FVIIa substrates (15, 16). This region of sTF is adjacent to the γ-carboxyglutamic acid 
(GLA) domain of FVIIa in the TF:FVIIA complex and together form a proposed binding site 
(exosite) for substrates, FX and FIX (15-17). The exosite interacts with the GLA domain of 
various substrates and is in close contact with the membrane surface. Though the structure of this 
exosite is paramount to substrate binding; current sTF:FVIIa crystal structures differ on the 
conformation of the exosite (10, 11). Additionally, the crystal structures are missing several 
residues in TF (K159-K165; 2A2Q and K159-S163; 1DAN) between 159 and 184, the putative 
exosite (16, 18). Membrane interactions with TF, which are missing in the sTF crystal structures, 
are likely to play a key role in determining which conformation the exosite adopts in the 
TF:FVIIa complex.  
Solid-state NMR (SSNMR) is a potent technique used to investigate conformational and 
dynamic changes of proteins at atomic resolution. Protein 13C and 15N chemical shifts are highly 
dependent on secondary structure (19), as well as on the electrostatic environment, crystal 
contacts and solvent exposure. Here we present chemical shift assignments for nanocrystalline 
sTF by SSNMR. We compare these assignments with previously reported solution NMR 
backbone chemical shifts for sTF (manuscript in prep, see chapter 7). Included in the chemical 
shift assignments are key residues that are near the membrane surface in membrane bound TF 
(membTF) and involved in the putative exosite of the TF:FVIIa complex ,as well as residues that 
interact with FVIIa. Additionally, we show initial SSNMR spectra of membTF embedded in 
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Nanodiscs (20), a membrane mimetic. Comparing the unbound sTF with membTF spectra and 
using chemical shift perturbation we report a preliminary conformational change of a loop 
(residues 159-165) in the extracellular domain of TF upon membrane insertion. These residues 
are contained in the proposed TF:FVIIa exosite (residues 159-184) (10, 11) whose conformation 
and interaction with the membrane surface is key to understanding the binding of substrate to the 
TF:FVIIA complex. These studies give key insights into the structure and membrane interactions 
of membTF and are the starting point for understanding the allosteric activation and substrate 
binding of the TF:FVIIA complex.  
8.4 Experimental Procedures 
8.4.1 Recombinant Protein Expression. 
For uniformly labeled 13C, 15N-sTF and 13C, 15N-membTF proteins, cultures were grown in 
BioExpress (a isotopically labeled algal hydrolysate; Cambridge Isotopes Labs), 13C-glycerol and 
phosphate. Specifically, 10X 13C, 15N-BioExpress is diluted to 1X concentration with 100 mM 
phosphate buffer at pH 7.5. 13C-glycerol is added to achieve a 0.2% mass ratio (i.e. 2 grams of 
13C-glycerol in 1 liter). A starter culture was grown at 37 °C to OD600 = 6 in a modified Studier 
medium (21) (MDG) with natural abundance isotopes. MDG media contains 25 mM Na2HPO4, 
25 mM KH2PO4, 5 mM Na2SO4, 2 mM MgSO4, 0.2% NH4Cl, 0.4% glucose (pH ~7) and 
supplemented with trace metals. The cells were then harvested and transferred to 3 volumes of 
fresh BioExpress media containing isotopes, and the culture was grown at 25° C until the OD 
reached ~3. Expression of sTF was induced with 20 µM IPTG for 24 hours. Expression of 
membTF was induced with 0.1 mM IPTG for 4 hours.  
For proteins grown with either 1,3-13C-glycerol or 2-13C-glycerol, cultures were grown using 
the MDG media that contained 25 mM Na2HPO4, 25 mM KH2PO4, 5 mM Na2SO4, 2 mM 
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MgSO4, 0.2% 15N-NH4Cl, 0.4% 1,3-13C-glycerol (or 2-13C-glycerol), pH ~7, supplemented with 
trace metals. Starter growths, expression and purification protocols are the same as for uniform 
labeled sTF. This protocol results in a yield of 20-30 mg sTF per liter. 
8.4.2 Soluble Tissue Factor purification.  
The cells were harvested, sTF released by osmotic shock, and the cell debris pelleted. The 
supernatant was treated with Q-Sepharose to remove a large fraction of the contaminating 
protein, and was then applied to a Ni affinity column. Fractions containing sTF were 
concentrated and the solution was then subjected to high-resolution gel filtration chromatography 
(HiPrep 16/160 Sephacryl S-200, GE Biosciences). This protocol results in a >95% purity, and a 
yield of 70-100 mg sTF per liter.  
8.4.3 Membrane Tissue Factor purification.  
The cells were harvested and suspended in a lysis buffer that contained 2.5% (w/v) 
octylglucoside in 50 mM phosphate buffer, pH 7.4, 50 mM NaCl and 0.1% NaN3. Benzonase 
(Novagen) is added to remove DNA and RNA. The cells debris was pelleted and the supernatant 
was treated with Q-Sepharose to remove a large fraction of the contaminating protein. The 
membTF protein contains a HPC4 epitope tag and after the Q-Sepharose the solution was applied 
to a HPC4 affinity column. Fractions containing sTF were concentrated and incorporated into 
Nanodiscs following previously published procedures (22). 
8.4.4 SSNMR Spectroscopy. 
Nanocrystalline sTF was prepared for SSNMR experiments by addition of 15% PEG 3350 to 
a 1 mM sTF sample in phosphate buffer (pH 7.5) and allowed to crystallize at 20 °C overnight. 
To confirm sample integrity, nanocrystalline sTF was dissolved in a phosphate buffer (pH 7.5) 
and the clotting activity measured. The re-dissolved sTF Nanocrystals retained >95% of its 
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activity, confirming that crystallization does not adversely affect the sample. Nanocrystals 
samples of sTF were grown with 1, 3-13C glycerol, 2-13C glycerol and with uniform 13C labeling  
and were packed into 3.2-mm rotors with ~6-9 mg protein in standard wall rotors and ~10-15 mg 
in thin wall rotors. All samples contained uniform 15N labeling. Nanodiscs containing 13C, 15N-
membTF were lyophilized and rehydrated in the rotor at a 2:1 sample mass:water ratio. Protein 
assays and NMR experiments (calibrated to 13C standards) indicate that 1.5±0.5 mg of membTF 
protein was packed into the 3.2 mm standard rotor.  Experiments were performed on a 14.0 Tesla 
(600 MHz 1H frequency) Varian Infinity Plus spectrometer and a 17.6 Tesla (750 MHz 1H 
frequency) Varian Unity Inova spectrometer equipped with Varian BalunTM 1H-13C-15N 3.2-mm 
probes. All data was acquired at 10±3 °C actual sample temperature (determined by ethylene 
glycol calibration) (23). All experiments utilized tangent ramped cross polarization (24) with 
TPPM (25) decoupling of the protons applied during acquisition and evolution periods at ~80 
kHz. For 3D 15N-13C-13C and 13C-15N-13C correlation experiments, band-selective SPECIFIC CP 
(26) was used for polarization transfer between 15N and 13C. Other experiments were performed 
according to published procedures as cited in the main text.  Hard π/2 pulse widths were 
typically 3.0 µs for 1H and 13C, and 4.5 ms for 15N. Backbone and side chain assignments were 
based on several spectra; two-dimensional (2D) 13C-13C spectrum, 2D NCA and NCO spectra, 
and three-dimensional (3D) NCACX, NCOCX and CANCO spectra. 
Spectra were processed with NMRPipe (27) employing zero filling and Lorentzian-to-
Gaussian line broadening for each dimension before Fourier transformation. Back linear 
prediction and polynomial baseline correction were applied to the frequency domain in the direct 
dimension. Chemical shifts were referenced externally with adamantane (assuming the 
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downfield peak to resonate at 40.48 ppm) (28). Additional experimental details are listed in the 
figure captions. Peak picking and assignments were performed with Sparky (29). 
8.5 Results and Discussion 
8.5.1 Solid-State NMR Assignments of soluble Tissue Factor. 
 
Figure 8.1 13C-13C 2D spectra of nanocrystalline sTF. 
(a) 13C-13C 2D spectrum of PEG-precipitated U-13C, 15N-sTF (12 hrs, 750 MHz, 25 ms DARR mixing). 
Expansions of the (b) valine Cα-Cβ region, (c) threonine Cα-Cβ region, and (d) isoleucine Cγ-Cδ region 
are shown with assignments.  
SSNMR assignments were carried out using a recently published strategy (30) and involved 
several 2D and 3D data sets collected on three nanocrystalline samples; a uniform 13C, 15N-sTF; 
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a 1,3-13C glycerol, 15N-sTF; and a 2-13C glycerol, 15N-sTF (see experimental section). The 
nanocrystalline sTF preparation produces highly resolved spectra with 13C line widths of ~0.3 to 
0.5 ppm. Initial SSNMR investigation of sTF began with a 13C-13C 2D DARR (31, 32) spectrum 
(Figure 8.1). This spectrum is similar to the HSQC “fingerprint” spectra in solution NMR and 
gives insight into the secondary structure of the protein. In the 13C-13C 2D spectrum (Figure 8.1) 
we are able to assign amino acid types to valine, threonine, serine, isoleucine, and alanine spin 
systems. Integrated intensities and peak counts of the resolved spin systems are consistent with 
properly folded sTF as compared to crystal structures (5-9). Backbone N, Cα, CO as well as Cβ 
side-chain assignments were previously published (BMRB XXXX) for sTF (manuscript in prep; 
see chapter 7) and were used to assist assignment of SSNMR data. However, all 13C, 15N 
assignments made in SSNMR spectra were confirmed through intermolecular correlations using 
2D and 3D spectra.  Using these strategies allowed for  ~80% of the sTF residues to be assigned 
in the SSNMR data. Correlation assignments for the valine and threonine Cα-Cβ’s and 
isoleucine Cγ-Cδ’s are labeled in Figure 8.1, demonstrating the completeness of assignments. 
The full extent of the SSNMR assignments are mapped onto the crystal structure (pdb: 2HFT) 
(9) in Figure 8.2.  Residues lacking assignments (black) are predominantly found in the first 
fibronectin type III domain at the end of β-sheets (i.e. 76-78) and in unstructured loops and turns 
(i.e. 82-85, 88-91). Secondary structural prediction using TALOS (33) were performed and are 
consistent with the X-ray crystal structures (5-9).  
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Figure 8.2 Structure of sTF. 
X-ray crystal structure of sTF (pdb: 2HFT; (9)) color-coded according to assignment completion. 
Residues assigned in the SSNMR spectra are colored yellow; residues lacking assignments are in black. 
Residues that differ in chemical shifts significantly (>1.0 ppm) between solution and solids data are 
rendered in red with the side-chains drawn and labeled.    
8.5.2 Comparing solution and SSNMR data.  
Previous studies have shown little variation (<0.5 ppm in 13C) in solution state and solid-state 
NMR chemical shifts of proteins (30, 34-39). Perturbations are usually attributable to sample 
preparation, crystal packing interactions or the solvent accessibility of the residue. In both the 
solution and nanocrystlline sTF samples the chemical shifts were consistent with properly folded 
sTF, though; there were slight differences in the sample preps. The solution sample was prepared 
in a 50 mM phosphate buffer, pH 6.5 with 50 mM NaCl (manuscript in prep; see chapter 7). The 
SSNMR nanocrystalline sample contained 25 mM phosphate buffer, pH 7.5 and precipitated 
with PEG with no additional salt added (see experimental section). To investigate the variation 
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between solution and SSNMR assignments we plotted the SSNMR assignments verses the 
solution NMR assignments for the Cα, Cβ, N and CO atoms (Figure 8.3). Regression analysis of 
the plots resulted in R2 values between 0.956-0.999, indicating an overall agreement between the 
solution and SSNMR data. There is very little change in the Cα and Cβ assignments (Figure 
8.3a, b) whose chemical shifts are highly sensitive to changes in secondary structure, indicating 
no measurable change in conformation between the two samples. The N and the CO are more 
dependent on hydrogen bonding and electrostatic effects and showed slightly more variation, 
with a few residues whose chemical shifts differed by more than 1.0 ppm (Figure 8.3c, d). These 
residues are highlighted on the sTF crystal structure (Figure 8.2) and are most likely due to 
electrostatic and crystal packing interactions.  
 
Figure 8.3 Solid-state versus solution state chemical shift assignments of sTF. 
(a) Cα, (b) Cβ, (c) N, and (d) CO solid-state versus solution state chemical shift assignments of sTF.  
Labeled residues are for those that differ by greater than 1.0 ppm. 
  153 
8.5.3 Membrane TF in bilayers. 
 
Figure 8.4 13C-13C 2D spectrum of Nanodisc-embedded U-13C,15N-membTF. 
(a) Residues 217 to 243 of membTF are shown with the residues in the transmembrane helix in red. (b) 
13C-13C 2D spectrum U-13C, 15N-membrane bound TF (green; 36 hrs, 600 MHz, 50 ms DARR mixing) 
overlaid with 13C-13C 2D spectrum of PEG-precipitated U-13C, 15N-sTF (red). Expansions of the (c) 
serine Cα-Cβ region, (d) helical valine and isoleucine Cα-Cβ region, and (e) alanine Cα-Cβ region with 
assignments for the some sTF resonances shown. * Note: the intense peaks at 60.18, 67.91 ppm and 
59.55, 66.26 ppm are from the Cα-Cβ correlations from isotopically labeled 13C, 15N-phosphatidylserine 
headgroups. 
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To investigate conformation changes in the extracellular domain of TF due to interactions 
with the membrane we prepared a U-13C, 15N membTF sample that contained the transmembrane 
helix (residues 219-243) (Figure 8.4a) and embedded it into Nanodiscs, a membrane mimetic, to 
study by SSNMR. Traditional methods used to investigate atomic resolution structural 
information, such as solution NMR and X-ray crystallography, have had limited success with 
large membrane bound proteins. SSNMR has a unique advantage over these traditional 
techniques in that it does not require single crystals and has no size limitations as found for X-
ray crystallography and solution NMR, respectively. An initial 13C-13C 2D spectrum was 
acquired for the membTF sample (Figure 8.4). The overall resolution of the spectrum is 
comparable to the nanocrystalline sTF 13C-13C 2D spectra (Figure 8.1) and a large number of 
resolved resonances are visible. Further comparison with the 13C-13C 2D spectrum of sTF shows 
that many of the chemical shift patterns—especially among the beta-sheet conformation 
signals—are unchanged or only slightly changed in the membTF relative to sTF.  This is 
expected since most of the protein does not directly interact with the membrane surface. Several 
new resonances are observed in the spectrum which can be attributed to residues 219-243 of the 
transmembrane helix (Figure9.4d, e). This portion of the sequence (Figure 8.4a) includes several 
new Ile and Val residues, as well as two Ala residues.  All of these signals appear in the 2D 
spectrum at positions indicating helical secondary structure (Figure 8.4d, e), which are not 
observed in the sTF spectrum.  
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Figure 8.5 Membrane interactions with the 2nd  fibronectin type III domain of sTF. 
C-terminal fibronectin type III domain of sTF is shown (pdb: 2HFT (9)) with loops (residues 159-165, 
179-185, 119-122) likely to interact with the membrane surface in red. S161 and S162 are missing from 
the crystal structure and are indicated with a dotted line. The blue box represents the membrane surface. 
Interactions of the extracellular domain of membTF with the membrane surface and the 
formation of TF dimers in the membrane will likely cause conformational changes that are 
observable as changes in sTF backbone chemical shift values.  Formation of TF dimers in the 
membrane is the consequence of an interaction between neighboring transmembrane helices 
(40). The formation of TF dimers and membrane interactions with the extracellular domain of TF 
likely play a key role in activation of the TF:FVIIa complex (41) and are lacking information in 
current X-ray structures (5-9). Figure 8.5 shows the C-terminal fibronectin type III domain of 
sTF and indicates three loops that are likely to interact with the membrane surface. One loop 
contains S160, S161, S162 and S163 whose Cα-Cβ chemical shift values show large 
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perturbations (Figure 8.4c) in the membTF sample consistent with a change in conformation due 
to interaction with the membrane surface. Changes in the alanine Cα-Cβ chemical shifts (Figure 
8.4e) could be due to a combination of the membrane interactions and the formation of TF 
dimers. The alanine resonance count in the Cα-Cβ region is consistent with expectations for both 
the membTF and sTF sample but display different chemical shifts indicating changes in the 
conformation of these residues. Alanine 168 and 191 are in the C-terminal fibronectin type III 
domain, with A168 in the β-sheet following loop 159-165. Interactions with the membrane 
surface could cause small perturbations in conformation of these residues. The rest of the alanine 
residues (2, 8, 9, 73, 80 and 89) are in the first fibronectin type III domain of sTF and changes 
due to direct interaction with the membrane are unlikely. Changes in these resonances are 
reasonably attributed to interactions due to the dimerization of TF in the membrane. More data is 
required and currently being performed to complete a full atomic resolution structure of 
membrane bound TF. 
8.5.4 Conclusion.  
We have presented 13C and 15N SSNMR chemical shift assignments for nanocrystalline sTF.  
Comparison of these chemical shifts shows an overall agreement to previously determined 
solution NMR assignments (manuscript in preparation, see chapter 7). A few residues contain 
major differences (>1 ppm) in the N and CO chemical shifts between the solution and SSNMR, 
which we attribute to slight changes in the electrostatics of the sample preps and possible crystal 
contacts. The chemical shift assignments include residues important in key interactions with 
FVIIa, the membrane surface and TF:FVIIa substrates. These include residues in a dynamic loop 
(72-92) that are key in allosteric activation of FVIIa (42, 43), residues 159 to 184 involved in the 
reputed substrate binding site (16, 18) and several residues likely to be involved in TF-membrane 
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interactions (Figure 8.5). Conformational changes and interactions of these residues can be 
analyzed by investigating perturbations to the chemical shifts upon formation of the various 
complexes (i.e. membrane bound TF, TF:FVIIa and TF:FVIIa:FX). SSNMR is uniquely capable 
to carry out these investigations since the complexes are too large for analysis by solution NMR 
and X-ray crystallography requires single crystals.  
A 13C-13C 2D spectrum of membTF was compared with sTF spectra. This analysis has given 
insights into membrane interactions with the extracellular domain of TF and the formation of TF 
dimers. Initial comparisons of the membTF and sTF 13C-13C 2D spectra revealed the expected 
resonances arising from the helical valine, isoleucine and alanine residues present in the 
transmembrane helix. Using chemical shift perturbation we report, for the first time, a loop in the 
extracellular domain of TF involved in membrane interactions in membTF. Loop 159-165 is 
contained in the C-terminal fibronectin type III domain of sTF and is near the membrane surface 
in membTF. Perturbation to the chemical shifts for S160 to S163 in the membTF 13C-13C 2D is 
strong evidence that loop 159-165 is interacting with the membrane surface. Interactions of both 
the C-terminal fibronectin type III domain with the membrane surface and formation of TF 
dimers in membranes are likely responsible for changes in the alanine chemical shifts reported 
for membTF. Changes for two alanines in the C-terminal fibronectin type III domain (A168, 
A191) could be due to membrane interactions. The other six alanines are all in the first 
fibronectin type III domain of sTF and changes in the chemical shift are more likely due to 
interactions involved in TF dimerization. Further studies are underway to determine all residues 
involved in membrane interactions and ultimately, to determine an atomic resolution membTF 
structure. 
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